Benign neoplasm of colon, rectum, anus and anal canal

CD2_BENIGN_COLORECANI_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12 Cause of death: ICD-10 — D12 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints CD2_BENIGN_COLON CD2_BENIGN_RECTOSIGMOID_JUNC CD2_BENIGN_RECTUM_ANAL	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum intestini crassi

NAME	CD2_BENIGN_COLORECANI_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_COLON\|CD2_BENIGN_RECTOSIGMOID_JUNC\|CD2_BENIGN_RECTUM_ANAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D12
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D12
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of colon, rectum, anus and anal canal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	29966	14727	15239
Unadjusted period prevalence (%)	5.88	5.02	6.72
Median age at first event (years)	65.48	64.11	66.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16255: Matched controls
136507

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

190.0

323.0

1882

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.7

323.0

1909

4693

A03FA01

ATC

metoclopramide; systemic, rectal

3.3

323.0

2941

8653

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

323.0

394

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

272.1

323.0

3803

153

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4656.8

323.0

545

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

208.1

323.0

2534

121

PJA12

NOMESCO Finland

Sentinel node biopsy

372.8

323.0

725

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

323.0

4800

19016

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

710.0

323.0

572

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

323.0

2059

5917

WF002

NOMESCO Finland

Radical radiotherapy

54.2

323.0

434

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

178.6

323.0

1257

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

323.0

4187

18532

C61

ICD-10 Finland

Malignant neoplasm of prostate

361.2

323.0

743

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

430

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

229.5

323.0

425

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

323.0

6327

29046

B01AB05

ATC

enoxaparin; parenteral

2.3

323.0

4728

20785

115

Kela drug reimbursment

Breast cancer

+∞

323.0

717

UJF30

NOMESCO Finland

Ileoscopy through colon

7.5

323.0

3537

4874

WX302

NOMESCO Finland

Thoracal epidural anesthesy

7.4

323.0

938

1123

JN4BD

NOMESCO Finland

Extensive body CT

6.6

323.0

1715

2385

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

43.4

323.0

1128

234

A02BC02

ATC

pantoprazole; systemic

2.2

323.0

10910

65406

L01BC06

ATC

capecitabine; oral

+∞

323.0

581

116

Kela drug reimbursment

Prostate cancer

+∞

323.0

346

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

213.8

323.0

753

A04AA02

ATC

granisetron; systemic, transdermal

148.9

323.0

680

JN4AD

NOMESCO Finland

Body CT examination

7.2

323.0

1126

1394

N02BE01

ATC

paracetamol; systemic, rectal

2.4

323.0

13793

95834

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

1113

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

531.9

323.0

5168

118

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

699

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

164.2

323.0

1886

109

H02AB02

ATC

dexamethasone; systemic

19.4

323.0

1103

510

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

5.6

323.0

5423

11158

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

246.7

323.0

3961

178

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

67.3

323.0

527

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

323.0

6949

34031

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

8.1

323.0

2995

3692

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

105.9

323.0

513

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.9

323.0

6893

21546

UJF32

NOMESCO Finland

Coloscopy

17.3

323.0

11235

15638

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

537

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

109.9

323.0

4427

464

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

466

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

323.0

4738

21187

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4361.4

323.0

512

HAB40

NOMESCO Finland

Wedge excision of mammary gland

21.8

321.1

503

200

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

557.4

308.2

326

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

170.4

302.4

338

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

300.0

3323

13584

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.8

299.8

1441

3432

L03AA13

ATC

pegfilgrastim; parenteral

889.4

298.1

312

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.7

292.9

1425

3427

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2511.0

292.5

302

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

291.4

1672

4582

HAC20

NOMESCO Finland

Total mastectomy

141.4

291.1

330

WX002

NOMESCO Finland

Sedation and analgesia

2.3

287.2

3330

13880

P01AB01

ATC

metronidazole; oral, rectal

1.9

284.7

6689

37095

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

243.1

284.3

311

N02AX02

ATC

tramadol; systemic, rectal

1.9

281.9

6925

38963

L02BG04

ATC

letrozole; oral

15.2

281.5

500

284

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

609.9

271.0

286

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

268.5

275

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

20.6

264.3

421

176

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

263.4

3666

16509

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

261.6

2111

7225

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

261.3

2241

7944

L02BA01

ATC

tamoxifen; oral

65.5

260.3

321

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

259.5

4776

24036

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

256.7

263

R4110

NOMESCO Finland

Physiotherapy

2.0

251.3

4077

19495

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

4.1

240.7

1050

2281

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

92.7

238.9

282

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

234.2

240

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

234.1

3370

15281

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

55.0

233.8

296

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

516.5

229.1

243

XX3DW

NOMESCO Finland

Time consuming IT work

3.8

228.8

1093

2570

J01DB01

ATC

cefalexin; oral

1.9

228.5

12759

90530

S18

ICPC

Laceration/cut

1.8

227.9

6027

33999

WF003

NOMESCO Finland

Adjuvant radiotherapy

179.8

227.2

253

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

226.6

1498

4500

ZX090

NOMESCO Finland

Other technic of radiotherapy

154.1

224.7

253

K92.1

ICD-10 Finland

Melaena

4.0

219.7

967

2113

ZX120

NOMESCO Finland

Intravenous

3.1

219.4

1361

3910

WF049

NOMESCO Finland

Radiotherapy of metastasis

395.4

217.8

233

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

217.7

2989

13234

A04AA55

ATC

palonosetron, combinations; systemic

1845.0

217.2

225

UJH02

NOMESCO Finland

Anoscopy

3.9

217.1

987

2220

A04AA01

ATC

ondansetron; systemic, rectal

5.4

216.1

707

1136

HA1AA

NOMESCO Finland

X-ray mammography

4.7

212.1

783

1439

A02BC05

ATC

esomeprazole; systemic

1.7

210.1

6598

38937

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

208.7

214

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.9

207.1

1459

4556

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1724.7

203.5

211

JFA42

NOMESCO Finland

Endoscopic injection in colon

130.6

201.6

230

WX402

NOMESCO Finland

General anaesthesia

2.2

201.4

2352

9659

C50.99

ICD-10 Finland

Breast, unspecified

600.0

200.7

212

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.9

199.6

605

884

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.0

197.9

699

1224

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

39.9

195.4

262

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

192.8

1457

4744

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

574.2

192.0

203

JN3AD

NOMESCO Finland

Abdominal CT examination

3.0

190.1

1231

3629

J01MA02

ATC

ciprofloxacin; systemic

1.7

189.3

5783

33538

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

840.6

188.9

198

A02BC03

ATC

lansoprazole; oral

1.7

186.2

4812

26517

N02AA05

ATC

oxycodone; systemic

2.5

186.0

1704

6184

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

1553.2

184.0

191

UKC02

NOMESCO Finland

Cystoscopy

2.2

183.2

2063

8298

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.6

182.1

895

2145

C03CA01

ATC

furosemide; systemic

1.8

180.3

3728

19081

JN4CD

NOMESCO Finland

Very extensive body CT

7.1

180.2

479

585

H02AB06

ATC

prednisolone; systemic

1.6

180.1

7080

43849

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

178.7

1824

6990

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

178.4

183

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

122.6

176.1

202

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

33.1

175.6

245

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

173.8

2613

11881

R06.0

ICD-10 Finland

Dyspnoea

1.8

173.6

3606

18448

B01AB10

ATC

tinzaparin; parenteral

3.5

172.5

885

2195

UJG02

NOMESCO Finland

Proctoscopy

6.2

171.8

499

689

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

50.6

171.5

220

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

167.7

172

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

166.9

1539

5587

N03AX16

ATC

pregabalin; oral

1.8

165.7

3701

19340

A06AD11

ATC

lactulose; oral

2.2

164.3

2032

8496

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.1

163.4

1010

2876

Z51.5

ICD-10 Finland

Palliative care

6.7

162.5

446

570

C50

ICD-10 Finland

Malignant neoplasm of breast

216.1

161.8

178

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

160.9

165

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

159.8

1341

4619

JFB30

NOMESCO Finland

Right hemicolectomy

16.7

159.0

271

138

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

158.9

163

XKD00

NOMESCO Finland

Uroflowmetry

2.2

158.2

1779

7117

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

157.0

8451

55890

J01MA12

ATC

levofloxacin; systemic

1.9

156.6

2603

12248

K63.5

ICD-10 Finland

Polyp of colon

8.5

156.1

366

367

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

156.1

4130

22668

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

154.0

158

A02BC01

ATC

omeprazole; systemic

1.7

153.4

4163

22996

WZC30

NOMESCO Finland

Teaching

2.3

150.1

1592

6185

C05AA08

ATC

fluocortolone; rectal, topical

1.9

150.1

2433

11323

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

148.2

152

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

335.3

147.7

159

L03AA02

ATC

filgrastim; parenteral

47.7

147.5

191

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

147.2

151

WX110

NOMESCO Finland

Local anesthesy

1.5

146.9

10004

69423

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

40.4

146.0

195

A04AD12

ATC

aprepitant; systemic

225.3

144.9

159

K62.1

ICD-10 Finland

Rectal polyp

10.6

144.1

299

240

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

143.3

147

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

84.9

142.8

170

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

141.3

145

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.9

141.3

956

2886

ZXC96

NOMESCO Finland

Robot assisted procedure

10.9

140.8

289

227

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

140.7

2013

8905

L02BB03

ATC

bicalutamide; oral

626.0

140.3

148

SPAT1153

SPAT

Removal of sutures

1.6

139.8

4329

24690

C07AB07

ATC

bisoprolol; oral

1.5

139.5

6730

42894

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

54.6

137.6

174

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

137.1

1001

3168

ZXA00

NOMESCO Finland

Right side

1.7

136.6

3877

21559

UJF92

NOMESCO Finland

Capsular endoscopy

5.3

136.4

454

741

AA1AD

NOMESCO Finland

CT of head and brain

1.7

136.3

3243

17124

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

135.5

139

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.5

135.1

1205

4276

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.7

133.1

263

191

D01

ICPC

Abdominal pain/cramps general

2.2

131.1

1515

6106

A07EC02

ATC

mesalazine; oral, rectal

2.7

130.8

1015

3328

NK6AN

NOMESCO Finland

Total body bone isotope imaging

23.4

129.8

198

N05CF01

ATC

zopiclone; oral

1.6

129.6

4698

27806

Y77

ICPC

Malignant neoplasm prostate

174.2

129.2

144

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

127.7

131

WF001

NOMESCO Finland

Preoperative radiotherapy

1122.2

126.6

132

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4.5

126.3

487

932

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

125.7

129

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

14.0

124.7

228

139

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

36.7

124.2

169

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

373.7

124.1

133

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

123.8

127

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

22.3

122.3

189

G04CA02

ATC

tamsulosin; oral

1.8

122.2

2533

12751

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

130.8

122.0

139

WW500

NOMESCO Finland

Blood transfusion

5.0

121.7

421

718

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

1074.0

121.7

127

WF004

NOMESCO Finland

Palliative radiotherapy

365.1

121.2

130

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

121.0

1512

6297

JG1BG

NOMESCO Finland

MRI of rectum

99.5

120.7

141

ZX070

NOMESCO Finland

Intensity modified radiotherapy

143.9

120.3

136

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

119.6

3212

17482

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

118.8

1183

4433

SPAT1263

SPAT

Sampling

1.5

118.5

5775

36458

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

117.9

1860

8505

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

116.5

796

2412

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

116.1

5724

36185

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

39.8

115.9

155

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

115.8

1046

3727

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.8

115.8

842

2652

JFF23

NOMESCO Finland

Transversostomy

17.3

114.4

192

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.1

113.6

476

987

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

113.1

415

754

N06AX11

ATC

mirtazapine; oral

1.5

113.0

4669

28307

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

113.0

116

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

112.2

3237

17923

R03AC02

ATC

salbutamol; inhalant

1.5

112.1

7720

52222

M79.6

ICD-10 Finland

Pain in limb

1.5

112.0

5133

31852

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

111.5

2223

11021

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

110.1

113

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.0

110.0

475

1013

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

16.7

110.0

187

C10AA01

ATC

simvastatin; oral

1.5

109.4

5937

38167

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

109.1

112

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

963.1

109.1

114

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

109.0

2216

11050

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

328.1

108.7

117

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

108.1

111

R53

ICD-10 Finland

Malaise and fatigue

1.7

107.8

2640

13936

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

322.3

106.8

115

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

72.8

106.5

129

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

105.9

2946

16113

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

105.4

6906

46031

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

104.9

5347

33833

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

104.9

2135

10636

JG1CG

NOMESCO Finland

Extensive MRI of rectum

47.6

104.5

135

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

467.9

104.4

111

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

104.1

496

1153

A02BA02

ATC

ranitidine; systemic

1.6

103.3

2923

16047

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

912.0

103.2

108

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.6

102.5

812

2688

X76

ICPC

Malignant neoplasm breast female

459.3

102.5

109

ZXA05

NOMESCO Finland

Left side

1.6

102.4

3453

19844

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

102.3

105

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

903.5

102.3

107

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

101.3

104

C08CA01

ATC

amlodipine; oral

1.5

101.0

4795

29819

KCD02

NOMESCO Finland

Transurethral resection of bladder

16.0

100.9

174

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

100.0

2541

13524

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.2

100.0

336

555

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

9.3

99.8

221

201

R50.9

ICD-10 Finland

Fever, unspecified

1.9

99.6

1622

7474

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.9

99.4

450

1001

L02AE02

ATC

leuprorelin; implant, parenteral

7.3

98.5

253

294

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

98.4

101

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.5

98.0

818

2787

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

97.4

100

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

153.5

97.0

109

M54.5

ICD-10 Finland

Low back pain

1.5

96.7

4671

29092

128

Kela drug reimbursment

Cancers of female genital organs

433.8

96.7

103

L02BG03

ATC

anastrozole; oral

39.0

96.2

129

M04AA01

ATC

allopurinol; systemic

1.9

95.8

1557

7162

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.6

95.8

472

1128

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

95.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

95.5

I84.5

ICD-10 Finland

External hemorrhoids without complication

3.1

94.8

582

1640

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

93.5

787

2692

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

827.0

93.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

93.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

93.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

92.9

1648

7817

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

92.8

639

1941

L02BG06

ATC

exemestane; oral

+∞

92.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

92.3

649

1999

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

126.7

92.1

105

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

91.8

604

1782

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

91.6

3167

18238

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

809.9

91.6

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

91.6

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

91.6

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

5.8

91.5

280

414

A10BA02

ATC

metformin; oral

1.5

90.9

3822

23030

D75

ICPC

Malignant neoplasm colon/rectum

90.4

90.8

107

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

801.4

90.6

21140

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Rectum

+∞

90.6

WX892

NOMESCO Finland

Monitored bed care

2.2

90.1

987

3856

C10AA05

ATC

atorvastatin; oral

1.4

89.9

5323

34438

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

89.6

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

16.1

89.5

154

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

89.5

1591

7547

ZX080

NOMESCO Finland

Image guided radiotherapy

142.2

89.4

101

D06

ICPC

Abdominal pain localized other

2.1

89.3

1097

4511

K51.5

ICD-10 Finland

Left sided colitis

3.2

89.2

515

1389

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

89.2

353

693

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

784.4

88.7

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

784.4

88.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

88.0

7185

49291

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.3

87.7

472

1209

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

391.1

87.0

A79

ICPC

Malignancy NOS

79.9

87.0

104

H02AB07

ATC

prednisone; oral

1.7

86.2

2063

10745

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

386.9

86.1

R03BB04

ATC

tiotropium bromide; inhalant

1.9

86.0

1339

6053

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

85.7

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

136.5

85.6

K30

ICD-10 Finland

Functional dyspepsia

1.8

85.6

1538

7317

R42

ICD-10 Finland

Dizziness and giddiness

1.6

85.0

2810

15963

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.5

85.0

270

418

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

84.7

A07EA06

ATC

budesonide; oral, local oral

2.9

84.7

571

1711

R31

ICD-10 Finland

Unspecified haematuria

2.1

84.1

1069

4458

K59.0

ICD-10 Finland

Constipation

2.4

83.9

753

2665

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

83.8

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

83.4

3381

20142

N05BA04

ATC

oxazepam; oral

1.5

83.4

3388

20195

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.9

83.3

544

1595

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

374.1

83.2

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

37.8

83.1

112

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

157.0

83.0

J01AA02

ATC

doxycycline; systemic

1.4

83.0

12070

91239

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

82.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

82.6

976

3942

SPAT1254

SPAT

Administration of medicine

1.8

82.5

1718

8572

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

82.3

363

789

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.1

81.5

490

1360

K29.7

ICD-10 Finland

Gastritis, unspecified

2.8

81.5

570

1749

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

81.5

668

2250

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

81.0

1433

6773

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

716.5

80.9

SPAT1262

SPAT

Handing over of treatment supplies

1.6

80.7

2350

12905

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

80.7

861

3319

Z93.3

ICD-10 Finland

Colostomy status

14.3

80.5

145

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

80.3

5522

36528

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

80.1

908

3598

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

80.0

640

2126

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

79.9

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

79.8

1792

9144

N03AX12

ATC

gabapentin; oral

1.6

79.6

2175

11738

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.6

79.4

247

373

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

699.5

79.0

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

78.9

3826

23637

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

78.9

TQW20

NOMESCO Finland

Tatoe

47.4

78.3

101

SPAT1301

SPAT

No procedures

1.5

78.3

3965

24712

D18

ICPC

Change in faeces/bowel movements

4.2

78.1

322

658

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

78.0

523

1561

K64.0

ICD-10 Finland

First degree haemorrhoids

4.7

78.0

287

524

UJD02

NOMESCO Finland

Gastroscopy

2.4

78.0

712

2541

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

+∞

77.9

G47.3

ICD-10 Finland

Sleep apnoea

1.5

77.8

3289

19731

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

77.4

1417

6773

J01CA04

ATC

amoxicillin; systemic

1.4

77.3

11780

89021

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

123.8

77.1

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

76.9

J01DA01

ATC

[U] cefalexin; systemic

1.4

76.7

9275

67337

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

5.2

76.2

253

413

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

76.1

1236

5664

E0000UV

ATC

1.4

75.9

5186

34171

L57.0

ICD-10 Finland

Actinic keratosis

2.2

75.8

851

3356

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

75.7

505

1502

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

75.7

2469

13936

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

13.5

75.5

139

R11

ICD-10 Finland

Nausea and vomiting

2.1

75.5

943

3899

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

143.5

75.4

T90

ICPC

Diabetes non-insulin dependent

1.5

75.0

3086

18379

D16

ICPC

Rectal bleeding

3.9

74.8

336

743

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

74.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

73.9

1392

6710

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

73.5

3647

22580

L04AX01

ATC

azathioprine; systemic

2.4

73.5

694

2520

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

73.4

2014

10865

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

52.3

73.4

A07AA02

ATC

nystatin; oral

2.2

73.1

825

3260

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

73.0

2674

15500

XJH00

NOMESCO Finland

Transanal ultrasonography

2.6

72.9

586

1951

A28

ICPC

Limited function/disability NOS

1.8

72.4

1501

7462

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

72.2

710

2629

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

72.1

3502

21575

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

72.0

2626

15203

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

10.7

71.8

147

116

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.1

71.4

425

1172

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

71.2

548

1780

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

71.1

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

71.0

2839

16773

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

70.8

1284

6109

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

70.8

509

1586

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

70.7

1590

8099

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.3

70.7

281

555

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

70.7

2142

11846

R51.80

ICD-10 Finland

Headache

1.6

70.5

1890

10125

J01FF01

ATC

clindamycin; systemic

1.4

70.3

3758

23577

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

28.4

70.3

101

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

70.1

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

70.1

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.9

70.0

186

228

A06AC51

ATC

ispaghula, combinations; systemic

2.3

70.0

727

2765

B01AA03

ATC

warfarin; systemic

1.6

69.9

2270

12774

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

47.5

69.9

XF402

NOMESCO Finland

ECG with work load test

1.7

69.8

1520

7667

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

69.7

5157

34326

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

69.4

400

1078

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

69.3

672

2473

Z31.5

ICD-10 Finland

Genetic counselling

2.6

69.2

539

1762

I84

ICD-10 Finland

Hemorrhoids

2.9

69.1

449

1313

JAH01

NOMESCO Finland

Laparoscopy

2.5

69.1

590

2029

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

8.4

69.0

162

164

ZZR00

NOMESCO Finland

Flap of skin

6.8

68.8

184

228

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.0

68.7

294

623

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

8.3

68.1

161

165

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

67.9

2092

11611

L17

ICPC

Foot/toe symptom/complaint

1.5

67.5

3223

19746

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

18.8

67.2

109

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

67.2

K55.2

ICD-10 Finland

Angiodysplasia of colon

10.6

67.1

138

110

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.0

67.0

421

1202

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

67.0

943

4089

R4190

NOMESCO Finland

Nutritional therapy

3.1

66.8

399

1103

J01EA01

ATC

trimethoprim; systemic

1.5

66.7

3204

19647

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.6

66.4

207

314

N06AX16

ATC

venlafaxine; oral

1.6

66.4

1899

10335

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

66.3

1675

8813

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

4.9

66.3

233

406

J01FA06

ATC

roxithromycin; oral

1.4

65.8

5822

39814

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.5

65.8

335

823

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

580.7

65.4

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

65.2

610

2204

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

65.1

2686

15941

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

64.8

5362

36244

A07EA02

ATC

hydrocortisone; rectal

3.0

64.4

397

1121

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

64.3

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

49.4

64.2

A04

ICPC

Weakness/tiredness general

1.7

64.1

1406

7099

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

64.0

937

4123

C03DA01

ATC

spironolactone; oral

1.8

64.0

1297

6391

SPAT1104

SPAT

Monitoring of emergency patient

2.0

63.8

868

3711

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

63.7

2477

14507

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

63.4

1580

8275

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

63.1

1413

7177

SPAT1325

SPAT

Vaccination

1.4

63.1

3819

24439

M48.0

ICD-10 Finland

Spinal stenosis

1.7

62.7

1540

8034

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

62.3

1467

7560

N06AB04

ATC

citalopram; systemic

1.4

61.9

3089

19044

TJF80

NOMESCO Finland

Ostomy education

10.4

61.7

128

104

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

61.5

3871

24923

JAH00

NOMESCO Finland

Laparotomy

3.2

61.3

346

918

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

24.8

61.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

61.1

2313

13451

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

60.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

60.4

R02

ICPC

Shortness of breath/dyspnoea

1.7

60.3

1441

7454

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

60.0

774

3238

N06AX21

ATC

duloxetine; oral

1.7

59.8

1538

8122

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

59.6

784

3306

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.4

59.6

541

1922

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

59.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

59.4

SPAT1097

SPAT

Recording of ECG

1.6

59.4

1869

10402

205

Kela drug reimbursment

Chronic hypertension

1.4

59.3

3479

22089

A10BH01

ATC

sitagliptin; oral

1.7

58.7

1230

6114

UJF34

NOMESCO Finland

Left colonoscopy

7.0

58.7

154

186

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

58.5

2011

11427

ZXA10

NOMESCO Finland

Bilateral

1.5

58.5

2222

12921

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.1

58.5

720

2952

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

58.4

1415

7343

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

58.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

58.4

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

58.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

58.4

J02AC01

ATC

fluconazole; systemic

1.3

58.3

5530

38011

K62.0

ICD-10 Finland

Anal polyp

4.7

57.5

210

382

SPAT1312

SPAT

General health counselling

1.4

57.1

3911

25493

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

57.1

2025

11588

H02AB04

ATC

methylprednisolone; systemic

1.5

57.0

2054

11793

B01AF02

ATC

apixaban; oral

1.8

56.9

1023

4839

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

177.0

56.8

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

56.5

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

+∞

56.5

C10AC01

ATC

colestyramine; oral

2.7

56.5

404

1256

N05CF02

ATC

zolpidem; oral

1.5

56.3

2445

14625

R19.4

ICD-10 Finland

Change in bowel habit

3.0

55.9

352

1008

Z71.8

ICD-10 Finland

Other specified counselling

1.4

55.9

2845

17563

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

55.8

1144

5646

R13

ICD-10 Finland

Dysphagia

2.0

55.8

796

3463

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

55.8

3082

19321

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

55.5

1461

7754

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.9

55.4

245

536

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

10.0

55.3

117

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

254.5

55.2

K57

ICD-10 Finland

Diverticular disease of intestine

3.0

55.2

338

951

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.9

54.9

363

1075

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

54.9

3742

24345

N30.0

ICD-10 Finland

Acute cystitis

1.6

54.6

1589

8656

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

54.5

G44.2

ICD-10 Finland

Tension-type headache

1.6

54.5

1717

9544

Z01.7

ICD-10 Finland

Laboratory examination

1.7

54.5

1382

7260

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

54.4

3715

24167

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.2

54.4

180

294

JFB43

NOMESCO Finland

Left hemicolectomy

11.3

54.3

108

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

54.2

5320

36647

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.9

54.2

355

1046

L03

ICPC

Low back symptom/complaint

1.4

53.9

3046

19157

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.2

53.9

572

2194

R05

ICD-10 Finland

Cough

1.5

53.8

2433

14659

D11

ICPC

Diarrhoea

1.7

53.7

1288

6660

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

53.7

847

3829

C01DA14

ATC

isosorbide mononitrate; oral

1.6

53.6

1633

8999

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

53.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

53.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.1

53.4

119

111

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

53.3

1576

8620

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.7

53.3

252

584

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

8.6

53.1

122

120

JFB46

NOMESCO Finland

Resection of sigmoid colon

4.9

53.0

184

317

R03BA02

ATC

budesonide; inhalant

1.5

52.6

2326

13940

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

52.6

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

52.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

52.3

2177

12887

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.0

52.2

318

892

R33

ICD-10 Finland

Retention of urine

2.0

52.2

739

3207

JN6AD

NOMESCO Finland

CT of torso and neck

10.4

52.1

108

C90.0

ICD-10 Finland

Multiple myeloma

162.9

52.1

R60.0

ICD-10 Finland

Localized oedema

1.7

51.8

1235

6372

R35

ICD-10 Finland

Polyuria

2.0

51.7

743

3241

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

51.4

1895

10918

WZA90

NOMESCO Finland

Other doctors statement

1.4

51.4

2943

18538

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

51.3

285

749

C09CA01

ATC

losartan; oral

1.4

51.2

3151

20102

Z51.0

ICD-10 Finland

Radiotherapy session

160.1

51.1

WX320

NOMESCO Finland

Spinalanesthesy

1.4

51.0

2821

17650

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

50.9

344

1034

G04BD12

ATC

mirabegron; oral

1.7

50.9

1110

5581

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.6

50.8

244

573

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

50.6

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

50.6

R01AD09

ATC

mometasone; nasal

1.3

50.5

6216

44089

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

232.6

50.4

N17

ICPC

Vertigo/dizziness

1.7

50.4

1220

6319

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

50.2

2474

15140

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

50.1

1520

8361

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

49.9

572

2274

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

49.9

1801

10322

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

49.9

313

895

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

445.1

49.9

SPAT1255

SPAT

Intravenous administration of medicine

1.9

49.9

773

3471

J01MA14

ATC

moxifloxacin; systemic

1.7

49.8

1106

5588

SPAT1216

SPAT

Assessment of functional ability

1.6

49.8

1645

9237

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

49.7

581

2330

M10.9

ICD-10 Finland

Gout, unspecified

1.9

49.6

741

3279

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

49.6

453

1615

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

49.6

911

4339

A46

ICD-10 Finland

Erysipelas

1.6

49.5

1641

9218

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

49.5

1404

7590

S29

ICPC

Skin symptom/complaint other

1.5

49.5

1899

11033

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

49.4

1245

6522

A01

ICPC

Pain general/multiple sites

1.8

49.2

920

4405

M25.5

ICD-10 Finland

Pain in joint

1.3

49.0

3906

25974

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

436.6

48.9

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

48.8

602

2471

L02BX02

ATC

degarelix; parenteral

+∞

48.7

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

48.7

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

48.7

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

48.7

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

48.6

2229

13440

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

223.8

48.5

R07.3

ICD-10 Finland

Other chest pain

1.7

48.3

1196

6235

KC1GB

NOMESCO Finland

Cystography with X-ray

21.1

48.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

48.2

3280

21253

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

48.1

776

3533

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

56.1

48.1

B01AC04

ATC

clopidogrel; oral

1.5

48.0

1733

9929

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

94.4

48.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

21.5

47.9

A11

ICPC

Chest pain NOS

1.8

47.9

924

4470

207

Kela drug reimbursment

Chronic arrhythmias

1.6

47.8

1482

8189

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

47.7

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

47.7

S77

ICPC

Malignant neoplasm of skin

22.0

47.6

N06AB10

ATC

escitalopram; oral

1.4

47.6

2569

15979

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.8

47.4

319

957

R52.9

ICD-10 Finland

Pain, unspecified

1.7

47.4

1043

5254

R06AE07

ATC

cetirizine; oral

1.3

47.2

5802

41021

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

47.2

928

4515

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

47.0

2013

11959

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.5

47.0

236

575

C07AB02

ATC

metoprolol; systemic

1.4

47.0

2480

15354

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

46.8

5354

37478

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

46.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

46.7

512

1994

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

46.7

2051

12250

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.8

46.7

165

291

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

33.7

46.6

D07AC01

ATC

betamethasone; topical

1.3

46.6

4538

31051

A02BC04

ATC

rabeprazole; oral

1.6

46.5

1180

6190

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

45.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

45.7

970

4833

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

45.7

1308

7080

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

28.8

45.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

45.6

4925

34167

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

143.2

45.4

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

45.3

837

3989

M05BX04

ATC

denosumab; parenteral

2.4

45.3

420

1511

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

45.3

1486

8320

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

45.2

697

3121

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

89.3

45.2

K60.1

ICD-10 Finland

Chronic anal fissure

2.6

45.2

347

1127

B82

ICPC

Anaemia other/unspecified

3.0

44.9

277

785

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

44.9

920

4533

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

44.9

592

2496

J45

ICD-10 Finland

Asthma

1.6

44.8

1217

6500

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

44.8

S21

ICPC

Skin texture symptom/complaint

1.6

44.6

1345

7377

TK800

NOMESCO Finland

Hemodialysis

2.8

44.6

307

935

M03BX02

ATC

tizanidine; oral

1.3

44.5

9311

70195

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

140.3

44.4

K02.1

ICD-10 Finland

Caries of dentine

1.3

44.4

7660

56396

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

44.3

2107

12777

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

44.3

7254

53060

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

44.2

614

2642

A11CC03

ATC

alfacalcidol; systemic

2.8

44.0

304

927

B01AB04

ATC

dalteparin; parenteral

2.1

43.9

519

2092

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

+∞

43.8

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

43.8

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

43.8

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

43.8

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

43.8

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

43.8

2153

13139

H25.8

ICD-10 Finland

Other senile cataract

1.7

43.8

1010

5156

R03AC03

ATC

terbutaline; inhalant

1.5

43.7

1834

10839

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

43.7

1024

5252

R15

ICD-10 Finland

Faecal incontinence

2.6

43.5

347

1151

A10BB12

ATC

glimepiride; oral

1.8

43.4

806

3847

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

73.0

43.3

JFB00

NOMESCO Finland

Partial resection of small intestine

3.9

43.2

187

403

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

385.8

43.2

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

385.8

43.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.1

43.1

178

367

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

43.0

444

1682

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

43.0

892

4411

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

42.8

JF2BD

NOMESCO Finland

Extensive colon CT

4.2

42.7

170

339

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

42.7

7751

57307

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

50.5

42.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

42.6

9935

75682

SPAT1260

SPAT

Consultation of another employee

1.4

42.6

2101

12822

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

55.7

42.5

A03FA02

ATC

cisapride; oral, rectal

1.7

42.5

994

5092

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

36.9

42.4

D12

ICPC

Constipation

2.5

42.3

359

1234

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

42.3

868

4279

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

377.3

42.2

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

42.1

1158

6201

JFF10

NOMESCO Finland

Loop enterostomy

9.9

42.1

L01CA04

ATC

vinorelbine; systemic

+∞

41.9

K51.8

ICD-10 Finland

Other ulcerative colitis

3.3

41.8

227

589

WX882

NOMESCO Finland

High dependency care

2.7

41.6

297

925

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

41.6

312

1001

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.6

41.5

324

1062

L28

ICPC

Limited function/disability (L)

1.5

41.4

1662

9725

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.3

41.4

105

122

M01AX17

ATC

nimesulide; oral

1.3

41.3

3393

22566

D02

ICPC

Abdominal pain epigastric

1.8

41.1

698

3234

ZX112

NOMESCO Finland

Subcutaneous

4.4

40.9

158

306

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

40.9

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.2

40.9

420

1590

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

40.8

925

4698

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.9

40.7

107

131

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

129.1

40.7

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

129.1

40.7

R18

ICD-10 Finland

Ascites

3.9

40.6

178

388

127

Kela drug reimbursment

Transplant complication

3.1

40.5

232

626

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

40.3

590

2593

WX704

NOMESCO Finland

Intubation

1.8

40.2

802

3919

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

40.2

950

4880

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

39.9

575

2511

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

39.9

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

39.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

39.8

774

3749

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

39.8

1158

6286

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

39.8

1244

6875

SPAT1053

SPAT

Memory test

1.6

39.6

1209

6641

G04CA01

ATC

alfuzosin; oral

1.6

39.6

1198

6570

KAC10

NOMESCO Finland

Total nephrectomy with capsule

15.5

39.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

39.4

988

5161

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

39.4

388

1439

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

39.2

2345

14803

M02AA07

ATC

piroxicam; topical

1.3

39.1

5076

35888

L01

ICPC

Neck symptom/complaint

1.5

39.1

1652

9763

SPAT1211

SPAT

Application of soft bandage

1.6

39.1

975

5082

3AC01

NOMESCO Finland

4.1

39.1

163

340

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

38.9

497

2067

A10BH05

ATC

linagliptin; oral

2.1

38.9

486

2006

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

38.8

988

5183

D64.8

ICD-10 Finland

Other specified anaemias

3.6

38.7

185

435

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

38.6

996

5239

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

38.6

8677

65414

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.6

38.5

295

957

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

38.5

964

5031

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

21.6

38.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

38.4

265

809

A08

ICPC

Swelling

2.1

38.3

436

1728

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.2

38.3

216

574

U02

ICPC

Urinary frequency/urgency

1.5

38.2

1432

8250

J20

ICD-10 Finland

Acute bronchitis

1.6

38.2

1143

6247

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

38.1

3952

27117

-60

ICPC

Result test/procedure

1.8

38.0

654

3044

1CD02

NOMESCO Finland

+∞

38.0

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

38.0

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

38.0

-50

ICPC

Medication/prescr/renewal

2.1

37.9

477

1975

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

37.9

308

1032

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.3

37.8

149

295

N05AH04

ATC

quetiapine; oral

1.4

37.8

2015

12455

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.9

37.8

163

351

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.7

37.8

874

4463

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

37.6

998

5291

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

37.6

2697

17531

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

15.9

37.5

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

37.5

2281

14428

C09AA05

ATC

ramipril; oral

1.3

37.5

2889

18984

N06AA09

ATC

amitriptyline; systemic

1.5

37.4

1352

7726

M79.1

ICD-10 Finland

Myalgia

1.5

37.4

1533

9002

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

335.0

37.4

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

7.8

37.3

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.4

37.3

142

272

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.1

37.2

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

37.1

481

2013

K96

ICPC

Haemorrhoids

2.5

37.0

313

1074

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

37.0

2113C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA TUBULARE COLI]

+∞

37.0

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

37.0

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

37.0

K50.8

ICD-10 Finland

Other Crohn disease

2.9

37.0

236

686

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

117.8

36.9

N63

ICD-10 Finland

Unspecified lump in breast

1.9

36.7

565

2527

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.7

36.7

832

4220

M01AX05

ATC

glucosamine; oral

1.4

36.6

2508

16173

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

36.6

715

3469

R19.5

ICD-10 Finland

Other faecal abnormalities

3.2

36.6

202

531

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.2

36.5

146

293

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

36.5

406

1593

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.0

36.5

154

325

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

36.5

1394

8058

R03DC03

ATC

montelukast; oral

1.4

36.4

2056

12836

A01AB09

ATC

miconazole; local oral

1.6

36.4

1064

5784

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.5

36.4

178

427

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

36.3

1812

11056

N05BA01

ATC

diazepam; systemic, rectal

1.4

36.3

1714

10350

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

36.2

575

2602

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.0

36.1

223

633

B80

ICPC

Iron deficiency anaemia

3.0

36.1

225

644

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

36.1

259

810

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

36.0

341

1240

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

36.0

K62.7

ICD-10 Finland

Radiation proctitis

+∞

36.0

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

36.0

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

36.0

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

36.0

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

36.0

P20

ICPC

Memory disturbance

1.6

35.9

1047

5683

SPAT1310

SPAT

Counselling related to known health issue

1.3

35.9

3827

26314

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.9

35.9

154

330

S82

ICPC

Naevus/mole

1.5

35.9

1315

7533

ICD-10 Finland

2.4

35.8

326

1163

J01FA09

ATC

clarithromycin; systemic

1.3

35.7

4301

30046

G04BE03

ATC

sildenafil; oral

5.4

35.6

112

174

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

35.6

172

408

R96

ICPC

Asthma

1.6

35.6

1057

5763

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

35.5

546

2443

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

35.5

226

656

J05AB11

ATC

valaciclovir; oral

1.5

35.5

1517

8979

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

318.0

35.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

35.3

4029

27948

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

35.2

6553

48172

XF404

NOMESCO Finland

Ambulatory ECG

1.6

35.2

1066

5842

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

35.1

1569

9366

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

35.1

659

3157

WX290

NOMESCO Finland

Other blockade of nerve

1.2

35.1

5710

41338

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

9.1

35.1

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

35.0

C10AA07

ATC

rosuvastatin; oral

1.3

34.9

3220

21696

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

36.0

34.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

34.9

1011

5479

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.0

34.9

216

615

SPAT1125

SPAT

Stoma care and guidance

3.9

34.8

149

319

C10AA04

ATC

fluvastatin; oral

1.6

34.7

924

4900

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.2

34.7

194

516

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

34.6

856

4451

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

34.6

1139

6367

WX722

NOMESCO Finland

PEEP

1.8

34.5

619

2921

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

34.5

1224

6960

R10.0

ICD-10 Finland

Acute abdomen

2.2

34.4

382

1499

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

34.4

621

2935

S97

ICPC

Chronic ulcer skin

1.9

34.3

567

2603

N05CD07

ATC

temazepam; oral

1.4

34.3

1572

9431

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

23.9

34.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

34.1

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

34.1

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

34.1

2114X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[NEOPLASMA BENIGNUM ALIUD RECTI ET CANALIS ANALIS]

+∞

34.1

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

34.1

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

34.1

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

34.1

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

34.1

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

34.1

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

33.9

230

695

JAL30

NOMESCO Finland

Omentectomy

6.5

33.8

119

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

33.8

948

5094

SPAT1229

SPAT

Assessment of need for aid

1.7

33.6

823

4267

C82.1

ICD-10 Finland

Follicular lymphoma grade II

301.1

33.5

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

33.4

676

3316

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

33.4

1190

6773

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

33.3

277

943

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

33.3

1018

5591

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

11.4

33.2

A10AE04

ATC

insulin glargine; parenteral

1.5

33.2

1097

6135

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

57.4

33.2

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

33.1

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

33.1

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

33.1

N19

ICD-10 Finland

Unspecified kidney failure

2.3

33.0

326

1210

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.3

33.0

175

448

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

6.8

33.0

108

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

32.9

3177

21514

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

8.9

32.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

32.7

809

4206

J01MA06

ATC

norfloxacin; oral

1.4

32.7

1714

10542

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

32.7

663

3256

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

292.6

32.6

K83.0

ICD-10 Finland

Cholangitis

3.3

32.4

170

431

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

32.3

1102

6206

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

32.3

232

726

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

32.3

724

3661

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

151.4

32.3

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

151.4

32.3

HAE99

NOMESCO Finland

Other reconstruction of breast

12.2

32.3

K62.3

ICD-10 Finland

Rectal prolapse

3.1

32.2

191

529

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

32.2

261

877

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

32.2

2453

16048

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

103.8

32.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

32.1

782

4048

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

32.1

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

32.1

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

32.1

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

32.1

2113X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[NEOPLASMA BENIGNUM ALIUD COLI]

+∞

32.1

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

4.0

32.1

135

285

R03BA01

ATC

beclometasone; inhalant

1.4

32.0

1779

11057

K58

ICD-10 Finland

Irritable bowel syndrome

2.4

31.9

291

1038

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

31.6

2487

16345

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

284.1

31.6

JFB50

NOMESCO Finland

Other resection of colon

12.0

31.5

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.6

31.5

248

819

H01CB03

ATC

lanreotide; parenteral

48.1

31.5

WX600

NOMESCO Finland

Single shot through catheter

3.5

31.4

157

384

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.2

31.4

351

1383

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

27.1

31.3

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

101.0

31.2

R01AD08

ATC

fluticasone; nasal

1.3

31.2

3725

25904

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

31.2

2929

19745

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

31.1

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

31.1

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

31.1

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

31.1

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

31.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

31.1

230

734

L05

ICPC

Flank/axilla symptom/complaint

1.7

31.1

617

3009

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

31.1

1322

7807

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

31.1

249

830

K78

ICPC

Atrial fibrillation/flutter

1.7

31.1

665

3317

R05

ICPC

Cough

1.3

31.1

2585

17128

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

31.1

897

4854

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

31.0

451

1977

C07AA05

ATC

propranolol; systemic

1.3

31.0

2447

16086

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.5

31.0

147

H01CB02

ATC

octreotide; parenteral

18.3

31.0

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

30.9

190

540

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

30.9

340

1330

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

30.8

369

1498

SPAT1285

SPAT

Provision of consultation response

1.8

30.8

608

2959

WX004

NOMESCO Finland

Patient-controlled sedation

5.4

30.7

149

K29.8

ICD-10 Finland

Duodenitis

3.6

30.7

145

339

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.7

30.7

618

3026

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

30.7

958

5286

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.7

30.5

218

682

C08CA13

ATC

lercanidipine; oral

1.4

30.5

1502

9126

K56.7

ICD-10 Finland

Ileus, unspecified

3.1

30.5

179

492

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

10.4

30.4

JHA00

NOMESCO Finland

Anal or perianal incision

3.0

30.4

188

537

A06AH03

ATC

naloxegol; oral

8.0

30.4

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

30.4

497

2274

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

30.4

2685

17937

EBA00

NOMESCO Finland

Extraction of tooth

1.3

30.4

4050

28530

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

30.4

455

2016

U05

ICPC

Urination problems other

1.9

30.3

447

1969

M01AE02

ATC

naproxen; oral, rectal

1.2

30.3

7905

59833

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

30.3

273

972

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

30.2

1702

10595

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

30.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

30.2

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

9.1

30.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

30.1

649

3243

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

30.0

1387

8327

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

30.0

2033

13050

J01CA08

ATC

pivmecillinam; oral

1.2

30.0

4893

35265

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

29.5

29.9

UJF02

NOMESCO Finland

Peroral enteroscopy

4.8

29.9

105

186

N07BA03

ATC

varenicline; oral

1.7

29.8

673

3408

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

29.7

491

2253

K60.3

ICD-10 Finland

Anal fistula

2.5

29.7

237

790

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

5.1

29.6

159

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

29.6

1394

8397

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

29.6

1052

5979

AN1

Coronary angiography

1.5

29.6

1213

7111

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.0

29.5

182

519

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

29.5

144

346

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.8

29.5

197

592

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

26283

170426

2.46

320.79

26.4

14.3

4.0

mmol/l

0.11

25846

165397

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

961

1671

4.22

316.26

3.3

1.9

166.6

691.3

u/ml

0.76

862

1507

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2716

8793

2.33

314.19

8.8

9.5

0.7

1.90

2702

8737

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1660

4197

2.94

313.80

3.2

3.1

0.3

0.4

u/ml

2.30

947

2459

(3035350) Ketones [Presence] in Urine by Test strip

14225

77801

1.62

313.42

4.6

3.5

0.0

estimate

0.16

1935

13568

(3009261) Glucose [Presence] in Urine by Test strip

14353

78765

1.61

310.92

4.7

3.6

0.0

estimate

0.10

1928

13432

(3011397) Hemoglobin [Presence] in Urine by Test strip

7878

37153

1.71

308.23

4.5

3.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3224

11308

2.17

308.13

4.6

3.8

101.3

91.4

ng/l

6.26

2809

9606

(3042936) Bacteria identified in Isolate by Culture

5269

20150

2.07

307.65

2.2

2.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

7451

30313

2.03

307.65

1.8

1.7

1123.0

1175.8

nmol/l

4.77

5687

22842

(3015736) pH of Urine

11837

60143

1.70

307.65

4.4

3.4

5.6

5.4

—

(3030467) Casts [#/volume] in Urine by Automated count

9488

41015

1.98

307.65

3.9

2.9

0.4

e6/l

0.00

7304

30404

(3007164) IgA [Mass/volume] in Serum or Plasma

6831

26965

2.07

307.65

1.5

1.3

2.6

2.5

g/l

0.96

3836

16063

(3002032) Base excess in Venous blood by calculation

3813

13819

2.12

307.65

4.8

3.6

1.8

1.9

mmol/l

1.45

3156

11330

(40768797) Stomach Pathology biopsy report

6634

20976

2.65

307.65

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2904

8204

2.70

307.65

2.6

2.4

—

(3006315) Basophils [#/volume] in Blood

15879

75612

2.14

307.65

6.8

5.5

0.0

e9/l

1.61

13715

65100

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14568

67421

2.12

307.65

2.3

1.9

95.0

96.2

pmol/l

2.06

8032

34041

(3013826) Glucose [Moles/volume] in Serum or Plasma

18073

91548

2.14

307.65

6.0

4.3

6.9

6.8

mmol/l

3.77

17132

85265

(3033658) Prothrombin time (PT) actual/Normal

9218

36190

2.22

307.65

5.2

3.5

88.5

89.6

3.07

9016

35147

(3032080) INR in Blood by Coagulation assay

14066

62169

2.23

307.65

11.1

9.0

1.3

inr

0.86

3156

17791

(3015377) Calcium [Moles/volume] in Serum or Plasma

11112

47034

2.13

307.65

3.7

2.1

2.4

mmol/l

1.06

9461

39647

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6604

26045

2.06

307.65

3.5

2.1

2.5

2.4

mmol/l

13.92

5668

22240

(42870588) Differential panel, method unspecified - Blood

11600

49767

2.13

307.65

6.6

5.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7610

31977

1.96

307.65

1.3

1.2

1.8

1.7

u/ml

0.33

1754

8863

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6037

22914

2.12

307.65

3.4

2.6

2.5

2.9

e6/l

1.72

3448

12128

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1682

4076

3.07

307.65

1.5

1.4

274.0

283.5

ug/g

0.96

1023

2329

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12619

64862

1.70

307.65

2.6

2.2

78.2

1501.6

nmol/l

0.50

11209

57606

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4690

13677

2.74

307.65

4.0

2.8

239.2

240.9

u/l

0.21

4411

12716

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16489

75261

2.36

307.65

8.5

5.6

1.2

mmol/l

18.89

14489

63088

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10524

47447

1.93

307.65

3.4

2.9

1642.9

1372.2

ng/l

5.47

9160

40350

(3020630) Protein [Mass/volume] in Serum or Plasma

3450

11814

2.24

307.65

2.4

1.6

66.0

67.1

g/l

12.74

3111

10603

(3002256) Pathology report gross observation

4378

12793

2.71

307.65

1.3

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3874

13469

2.22

307.65

8.0

8.2

119.1

123.5

g/l

31.44

3763

12971

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4061

11039

2.90

307.65

2.6

2.1

0.2

g/l

3.57

3795

10008

(3027801) Oxygen [Partial pressure] in Arterial blood

4688

16457

2.24

307.65

7.2

7.3

12.0

11.8

kpa

2.50

4456

15695

(3019198) Lymphocytes [#/volume] in Blood

16071

77395

2.12

307.65

6.9

5.5

1.9

e9/l

0.45

14093

67876

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23178

118866

3.19

307.65

9.8

5.3

79.9

75.7

u/l

30.83

22145

110061

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10260

36561

2.58

307.65

2.8

2.2

3.3

2.9

mg/l

35.32

8909

31043

(3027945) Reticulocytes/100 erythrocytes in Blood

5008

15641

2.56

307.65

2.5

2.2

1.8

2.60

4414

13639

(3031040) Bacteria [#/volume] in Urine by Automated count

19630

100391

2.30

307.65

5.8

4.1

572.8

1477.4

e6/l

2.77

163

1527

(3014576) Chloride [Moles/volume] in Serum or Plasma

5322

17785

2.40

307.65

7.7

6.8

104.4

104.3

mmol/l

0.95

5228

17320

(3020779) Urea [Moles/volume] in Serum or Plasma

3708

12423

2.30

307.65

9.3

7.3

10.8

10.3

mmol/l

3.91

3509

11775

(3000991) Gas panel - Venous blood

3578

11571

2.38

307.65

8.7

8.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10288

49146

1.78

307.65

3.7

2.7

34.7

34.1

u/l

0.15

9668

46295

(3026008) Bacteria identified in Urine by Culture

9900

44633

1.90

307.65

3.7

3.0

—

(4035726)

3167

4621

5.39

307.65

1.4

1.2

—

(36304419) Bacteria [Presence] in Urine

9103

39688

1.94

307.65

3.8

2.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6568

25299

2.11

307.65

3.2

2.5

1.2

1.1

e6/l

0.13

3939

14405

(3023520) Reticulocytes [#/volume] in Blood

3768

11554

2.53

307.65

2.6

2.2

70.3

69.6

e9/l

0.50

2881

8721

(3019550) Sodium [Moles/volume] in Serum or Plasma

26269

169872

2.49

307.65

26.1

14.3

139.6

139.8

mmol/l

34.60

25860

165140

(40768804) Tissue Pathology biopsy report

14017

51115

2.90

307.65

2.5

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15312

67658

2.35

307.65

7.3

5.2

1.2

mmol/l

9.98

13999

60118

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4692

16464

2.24

307.65

7.2

7.3

5.1

kpa

1.05

4471

15705

(3000850) Epithelial cells [#/volume] in Urine

7181

30920

1.88

307.65

3.0

2.5

4.7

5.2

e6/l

3.25

6164

26860

(40758558) Short blood count panel - Blood

8598

34996

2.08

307.65

7.5

4.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

21550

120248

2.18

307.65

5.1

4.0

14.0

11.8

mm/h

78.45

20003

111158

(3016502) Oxygen saturation in Arterial blood

4213

14798

2.21

307.65

7.5

7.7

95.6

95.2

2.88

4082

14250

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2434

6180

2.98

307.65

1.7

1.6

g/l

0.71

2115

5253

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14848

65322

2.31

307.65

4.6

3.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12367

63084

1.71

307.65

4.6

3.5

42.5

76.1

ng/l

4.42

9152

43073

(3019069) Monocytes/100 leukocytes in Blood

14600

70195

2.00

307.65

7.3

6.0

8.8

8.6

7.33

13649

65216

(3021960) Folate [Moles/volume] in Serum or Plasma

8592

36837

1.96

307.65

1.7

1.5

20.7

20.5

nmol/l

0.44

7439

31229

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

449

231

14.09

307.65

3.1

1.1

35.4

27.6

u/ml

0.30

438

211

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17829

73989

2.95

307.65

7.2

3.8

11.3

11.8

umol/l

5.62

17023

69152

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8778

32051

2.39

307.65

2.8

2.1

—

(3022096) Basophils/100 leukocytes in Blood

14165

67754

1.99

307.65

7.1

5.7

0.7

3.58

13202

62674

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4774

15598

2.43

307.65

3.1

2.2

7.8

umol/l

0.06

4198

13344

(3044640) Blood type and Crossmatch panel - Blood

11236

42030

2.51

307.65

2.9

2.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

6818

22806

2.50

307.65

3.1

2.5

11.9

13.4

umol/l

46.09

6383

20878

(3014007) Fractional oxyhemoglobin in Arterial blood

2745

8802

2.36

307.65

8.8

9.6

93.7

93.4

1.93

2738

8770

(3001604) Monocytes [#/volume] in Blood

15798

75194

2.14

307.65

6.8

5.5

0.6

e9/l

7.43

13652

64733

(3003396) Base excess in Arterial blood by calculation

4686

16443

2.24

307.65

7.2

7.3

1.0

1.2

mmol/l

4.70

3720

12842

(3013115) Eosinophils [#/volume] in Blood

16286

78227

2.15

307.65

7.0

5.7

0.2

e9/l

10.30

14243

68388

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6394

20935

2.53

307.65

3.1

2.5

2.3

g/l

1.69

5959

19198

(3018418) pH of Serum or Plasma

9822

43905

1.92

307.65

5.1

3.3

7.4

1.27

1338

7914

(3022145) Colonoscopy Study observation

10443

13399

8.24

307.65

1.5

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

10025

44860

1.92

307.65

4.0

2.9

77.1

93.8

e6/l

0.53

7823

33925

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5081

18317

2.20

307.65

7.2

5.4

1.0

mmol/l

3.06

4745

16880

(3037467) Urinalysis macro (dipstick) panel - Urine

20042

108003

2.12

307.65

5.5

4.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5860

21576

2.19

307.65

3.7

2.6

0.8

mmol/l

25.88

5464

19755

(3013650) Neutrophils [#/volume] in Blood by Automated count

17864

82663

2.48

307.65

10.0

6.5

4.2

e9/l

0.53

15614

71026

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5759

23175

1.97

307.65

2.0

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

15759

62530

2.81

307.65

6.1

3.7

35.1

35.8

g/l

43.81

14831

57097

(3012544) pH of Venous blood

3913

14467

2.08

307.65

4.8

3.7

7.4

0.50

(3026782) Osmolality of Urine

6890

28364

1.97

307.65

3.3

2.6

537.3

545.4

mosm/kgh2o

0.58

5717

23885

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5592

22763

1.94

307.65

2.3

2.0

30.1

29.9

1.60

5437

22045

(3002030) Lymphocytes/100 leukocytes in Blood

14778

72076

1.97

307.65

7.2

5.8

26.4

28.2

64.47

13731

66580

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3565

9516

2.92

307.65

1.7

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1965

2896

5.13

307.65

3.5

2.0

850.2

96.9

u/ml

1.33

1675

2361

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3827

13847

2.13

307.65

4.8

3.6

5.8

5.9

kpa

2.40

3710

13445

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25788

160308

2.71

307.65

22.5

12.0

25.5

22.9

mg/l

28.42

22160

124103

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11619

48272

2.22

307.65

3.0

2.3

58.5

59.5

u/l

0.70

10810

44121

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13579

62401

2.07

307.65

3.7

2.7

134.5

128.4

ug/l

1.40

12591

57366

(3023368) Bacteria identified in Blood by Culture

9748

38140

2.26

307.65

5.0

3.8

—

(3018010) Neutrophils/100 leukocytes in Blood

14642

71148

1.98

307.65

6.9

5.6

58.4

57.1

33.35

13626

66062

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6114

7573

7.08

307.65

4.6

1.5

16.7

10.1

ug/l

0.57

5104

5602

(3048689) Calprotectin [Mass/mass] in Stool

5558

16996

2.66

307.65

2.4

2.2

145.6

133.3

ug/g

1.16

4444

13250

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4026

12701

2.47

307.65

2.8

2.3

46.6

44.6

u/l

0.09

3460

10716

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6092

19403

2.58

307.65

3.2

2.6

20.7

23.3

33.37

5272

16346

(3006504) Eosinophils/100 leukocytes in Blood

14540

69854

2.00

307.65

7.0

5.7

2.8

3.0

16.59

13557

64560

(3018095) Leukocytes [#/volume] in Urine

11524

52904

1.94

307.65

4.6

3.4

80.2

107.1

e6/l

3.41

8395

36932

(3014111) Lactate [Moles/volume] in Serum or Plasma

3695

12322

2.31

307.65

7.1

1.3

1.4

mmol/l

1.64

3548

11861

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2711

8868

2.31

305.94

8.7

9.4

1.4

0.66

2694

8804

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4136

16003

1.99

304.68

1.9

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

14181

77902

1.60

302.57

6.3

4.7

0.0

estimate

0.23

2013

13857

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6862

31387

1.74

297.62

4.5

3.7

512.5

589.8

ng/l

0.23

5697

24645

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2319

7204

2.42

293.11

8.9

9.8

24.2

24.4

mmol/l

2.89

2147

6578

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4103

16076

1.96

290.49

2.0

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5120

21718

1.84

284.31

31.6

24.9

1.5

1.4

inr

4.14

468

3097

(3026493) Urate [Moles/volume] in Serum or Plasma

8813

43812

1.63

275.74

3.1

2.3

4622.4

4948.6

umol/l

0.29

7646

37641

(3004588) Protein electrophoresis panel - Serum or Plasma

2907

10204

2.15

275.57

2.3

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7198

33960

1.69

275.46

2.0

1.7

1.3

1.1

mg/l

4.00

5627

26055

(3024354) Oxygen [Partial pressure] in Venous blood

3171

11541

2.08

273.80

3.9

3.0

4.6

kpa

0.09

3060

11163

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17785

104518

1.58

270.43

4.0

2.9

58.4

47.0

u/l

35.73

16513

96732

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23706

149970

1.80

268.96

5.6

4.6

2.0

2.1

mu/l

0.37

21783

136903

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10003

51628

1.59

266.12

2.3

2.1

193.5

220.0

u/l

2.26

9399

48204

(3014765) Yersinia sp identified in Stool by Organism specific culture

1532

4053

2.80

266.09

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1530

4063

2.79

263.86

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1514

4020

2.79

261.11

1.3

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

4239

17394

1.87

258.89

1.9

1.8

—

(40761511) CBC panel - Blood by Automated count

25788

168259

2.09

255.62

21.4

11.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2440

8231

2.22

254.07

1.9

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2094

6633

2.36

252.22

5.0

4.0

24.0

24.2

mmol/l

1.48

1883

5848

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20304

123997

1.60

251.31

4.5

3.9

15.0

14.8

pmol/l

13.55

18475

112426

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2239

7364

2.27

247.31

9.6

10.3

—

(3013512) EKG study

9251

47541

1.58

245.63

4.9

3.8

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

570

786

5.27

244.41

3.5

1.5

8.1

4.0

nmol/l

2.10

555

747

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

726

1280

4.13

234.30

2.8

2.0

182.6

720.8

u/ml

0.52

715

1241

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1148

2810

3.00

228.27

1.6

1.5

—

(3021589) Normoblasts [#/volume] in Blood

12345

68473

1.51

226.53

11.8

8.3

0.0

e9/l

0.59

10053

56214

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26290

174104

2.13

221.50

14.7

8.9

25.7

26.5

u/l

7.76

25643

166894

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1381

3821

2.66

219.63

1.3

1.2

—

(3019060) Gas panel - Arterial blood

2698

10006

2.02

218.78

4.7

4.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

166

51.85

217.69

1.0

—

(3044889) 12 lead EKG panel

19043

116208

1.52

215.43

4.7

3.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

26242

174034

2.08

212.08

26.2

13.9

83.4

77.9

umol/l

74.60

26234

173954

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

23906

154071

1.70

211.34

20.0

11.1

76.0

79.1

ml/min/173m2

94.54

20374

124441

(40768800) Prostate Pathology biopsy report

604

998

4.40

211.21

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2722

10302

1.98

208.08

2.7

2.3

10.6

10.9

g/l

2.79

2516

9358

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1769

5689

2.30

204.59

2.2

1.4

3.9

g/l

0.13

1212

4050

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1770

5699

2.30

204.13

2.2

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1771

5708

2.30

203.76

2.2

1.4

7.5

7.4

g/l

0.03

1256

4227

(3028026) IgM [Mass/volume] in Serum or Plasma

2237

8046

2.07

196.05

1.9

1.5

1.4

1.2

g/l

3.36

2045

7311

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2268

8207

2.06

195.58

1.6

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

10183

55527

1.48

193.14

4.4

3.9

12.0

8.0

mg/mmol

10.64

6767

34721

(36660697) Celiac disease serology panel - Serum

2886

11418

1.90

193.00

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

498

756

4.77

192.25

1.7

1.3

22.8

22.6

ug/l

0.01

486

738

(3049717) Cytology report of Urine Cyto stain

1538

4791

2.37

190.81

2.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1457

4455

2.41

188.25

2.7

2.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1645

5327

2.28

186.79

2.2

1.4

10.2

10.3

g/l

0.40

1346

4430

(3025941) Bacteria identified in Stool by Culture

2217

8125

2.03

184.31

1.4

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1647

5373

2.26

183.75

2.3

1.4

3.1

3.0

g/l

2.75

1238

4161

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23929

155532

1.65

183.66

7.5

5.9

40.9

40.1

mmol/mol

30.30

22277

143879

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1505

4740

2.34

182.01

2.4

1.5

0.9

0.5

g/l

4.86

1277

4044

(3012516) Albumin [Mass/volume] in Urine

9671

52655

1.47

181.81

3.6

3.2

550.4

325.9

mg/l

3.84

6469

32738

(40761535) Cells panel - Urine sediment

3177

13208

1.81

181.05

4.3

3.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3065

12619

1.82

180.24

2.3

1.8

364.6

365.9

nmol/l

0.13

2822

11477

(40768793) Breast Pathology biopsy report

555

976

4.12

179.55

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1437

4486

2.36

177.16

2.8

1.6

45.8

36.9

mg/l

0.55

1229

3573

(3009508) Creatinine [Moles/volume] in Urine

9896

54365

1.46

176.20

3.5

3.2

7.3

7.6

mmol/l

9.55

8324

45681

(3034860) Kappa light chains.free [Mass/volume] in Serum

1437

4505

2.35

175.46

2.8

1.6

93.7

45.9

mg/l

0.81

1230

3593

(3017143) Hepatitis C virus Ab [Presence] in Serum

3171

13312

1.79

174.57

1.7

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1401

4354

2.37

174.41

2.7

1.6

3.0

2.0

ratio

0.44

377

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3419

14719

1.75

172.62

2.5

2.3

6.1

8.2

ug/l

8.06

2943

12880

(3000494) Fungus identified in Specimen by Culture

4032

18170

1.68

172.59

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1481

4754

2.29

171.29

1.8

1.7

—

(3019225) pH of Specimen

3447

14976

1.73

168.22

5.1

3.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2174

8178

1.97

167.45

7.9

7.4

24.8

mmol/l

0.07

2154

8090

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10145

56472

1.44

165.62

5.5

3.6

3.0

2.2

ug/l

1.60

9127

50978

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1584

5313

2.20

164.93

2.1

1.9

2.1

ug/l

0.06

1404

4637

(3009542) Hematocrit [Volume Fraction] of Blood

22502

145106

1.53

164.32

24.5

13.2

38.6

40.0

72.55

14911

101734

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2435

9608

1.89

162.75

7.3

7.1

24.6

mmol/l

0.14

2293

8956

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1383

4432

2.29

160.36

2.3

1.4

37.3

37.8

g/l

2.00

1165

3754

(3004716) Salmonella sp identified in Stool by Organism specific culture

1830

6569

2.06

160.12

1.4

—

(3037121) Protein [Mass/volume] in Urine

1420

4616

2.26

159.25

3.2

2.7

0.3

0.4

g/l

0.27

644

1608

(3004119) Hemoglobin [Mass/volume] in Venous blood

2413

9563

1.88

158.96

4.2

3.2

124.9

131.5

g/l

33.75

2360

9348

(3013139) Helicobacter pylori Ag [Presence] in Stool

2631

10730

1.83

158.35

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1335

4237

2.31

158.23

2.4

1.5

0.0

g/l

1.16

1197

3859

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2395

9490

1.88

157.80

4.3

3.3

5.1

5.2

kpa

0.92

2220

8703

(3009343) pH of Capillary blood

2364

9351

1.88

156.53

4.3

3.3

7.4

2.57

231

1217

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2295

9010

1.89

155.45

4.3

3.2

1.5

1.8

mmol/l

3.28

1712

6636

(3019150) Specific gravity of Urine by Refractometry

6749

35092

1.49

154.10

5.2

4.0

1.0

kg/l

0.52

1056

5249

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3193

13919

1.72

152.95

3.2

2.9

234.0

207.3

ng/l

2.14

2912

12717

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1248

3919

2.33

151.42

2.4

1.5

0.0

g/l

0.27

1111

3553

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1229

3859

2.33

149.11

2.4

1.5

0.0

g/l

0.00

1111

3539

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1938

7304

1.96

147.81

3.5

2.7

1.3

0.08

1932

7266

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

24538

162282

1.61

147.28

5.7

4.7

6.1

6.0

mmol/l

49.57

22573

148250

(3022313) Gas panel - Capillary blood

1822

6733

2.00

146.90

4.4

3.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1619

5746

2.07

145.62

4.6

3.5

24.7

24.9

mmol/l

1.67

1488

5266

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1896

7145

1.96

144.55

3.4

2.7

0.7

0.08

1829

6824

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1890

7117

1.96

144.40

1.1

—

(3007461) Platelets [#/volume] in Blood

26656

180693

1.95

141.13

33.9

17.7

247.3

249.2

e9/l

4.52

26202

175064

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3312

14911

1.66

139.90

1.7

1.5

—

(3035941) MCH [Entitic mass]

26655

180788

1.94

138.70

33.8

17.6

30.3

30.4

6.89

26396

177594

(3024731) MCV [Entitic volume]

26657

180820

1.94

138.38

33.8

17.6

91.5

91.2

15.15

26397

177615

(3026361) Erythrocytes [#/volume] in Blood

26657

180836

1.94

138.01

33.9

17.7

4.4

4.5

e12/l

307.65

26123

174561

(3010813) Leukocytes [#/volume] in Blood

26658

180862

1.94

137.61

34.0

17.7

6.9

6.6

e9/l

51.29

26124

174595

(3000963) Hemoglobin [Mass/volume] in Blood

26659

180878

1.94

137.45

34.2

17.8

132.0

137.1

g/l

307.65

26406

177697

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4357

21225

1.55

132.26

9.9

6.5

—

(3037522) Nuclear Ab [Titer] in Serum

4444

21781

1.54

131.15

1.4

1.3

511.9

568.0

titre

1.16

942

4660

(3037756) Immunofixation for Serum or Plasma

942

2776

2.47

131.03

1.5

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1061

3311

2.34

130.30

2.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1549

5635

2.02

130.01

1.7

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

965

2906

2.42

128.16

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

965

2907

2.42

128.06

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

121

10.21

127.97

6.1

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1121

3614

2.27

127.73

2.6

2.5

3.7

3.6

g/l

1.12

1073

3427

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1493

5447

2.01

124.19

2.5

2.3

454.5

621.4

ug/l

1.12

1405

5124

(4010399)

2767

12235

1.68

124.18

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1266

4348

2.13

123.57

3.9

3.1

—

(3003694) ABO and Rh group [Type] in Blood

6876

37186

1.42

122.73

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1462

5318

2.02

122.58

3.1

1.5

45.2

27.2

u/ml

2.98

1399

5068

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

801

2261

2.57

121.65

6.6

6.1

881.9

1055.8

iu/ml

0.18

146

346

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

985

3076

2.33

120.68

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1778

6981

1.87

119.27

1.5

13.2

15.8

u/ml

0.33

181

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

854

2522

2.46

118.17

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2831

12778

1.65

117.05

2.8

2.3

61.3

65.2

ml/min/173m2

5.24

1211

4828

(40768795) Lymph node Pathology biopsy report

253

325

5.60

116.64

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1798

7140

1.85

116.35

5.3

3.7

48.4

47.9

0.32

1792

7058

(3042111) Morphology [Interpretation] in Bone marrow Narrative

641

1650

2.82

116.07

1.5

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1893

7690

1.81

113.82

4.5

3.2

25.1

25.4

mmol/l

2.52

1854

7461

(3020891) Body temperature

1606

6202

1.90

113.15

5.4

4.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

1447

5404

1.96

112.47

4.3

4.2

1.4

mmol/l

0.81

1420

5309

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8025

45104

1.38

112.35

4.7

3.5

22.0

23.9

23.22

4129

20487

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

204

217

6.76

111.97

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3669

17818

1.54

111.12

1.8

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1678

6636

1.86

109.82

1.1

223.4

203.5

titre

0.09

171

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1225

4356

2.05

109.00

1.5

13.8

18.4

iu/ml

0.42

120

(3034770) Mitochondria Ab [Titer] in Serum

1174

4123

2.08

107.95

1.3

1.2

966.9

1081.3

titre

0.21

147

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

751

2185

2.49

107.16

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1579

6209

1.86

105.07

5.3

4.8

0.9

0.02

1502

5855

(3007566) Smooth muscle Ab [Titer] in Serum

1164

4136

2.05

103.71

1.3

1.2

104.1

128.3

titre

0.51

367

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1595

6321

1.85

103.55

5.3

4.7

1.7

0.61

1517

5970

(3003434) Protein [Mass/volume] in Pleural fluid

561

1441

2.82

101.96

1.6

1.5

30.9

31.0

g/l

0.09

489

1280

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1950

8279

1.73

100.52

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

20338

132327

1.35

100.39

27.8

14.3

14.0

13.6

192.34

20058

129050

(3023199) Leukocytes [#/volume] in Pleural fluid

521

1298

2.90

100.01

1.5

1.4

1892.4

4478.2

e6/l

1.97

362

953

(3025468) Yersinia sp identified in Specimen by Organism specific culture

613

1683

2.64

98.29

1.5

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

522

1317

2.87

97.99

1.7

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

919

3046

2.19

97.74

3.7

2.6

35.1

33.3

umol/l

1.15

781

2600

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10274

60917

1.32

97.41

5.1

3.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

612

1690

2.62

97.02

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

611

1687

2.62

96.89

1.5

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1256

4721

1.94

95.55

4.5

3.9

mmol/l

1.65

1200

4436

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

612

1709

2.59

94.90

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

610

1711

2.58

93.76

1.5

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1101

3985

2.01

93.18

2.3

2.2

90.7

91.2

0.29

1048

3657

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6438

35802

1.37

92.70

1.8

1.7

28630139.7

35177694.1

pmol/l

0.44

5393

29448

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

622

1772

2.54

92.65

1.5

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5815

31818

1.38

92.47

3.2

2.6

0.8

0.7

ug/l

3.06

4265

20435

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1027

3633

2.06

92.47

2.5

200.5

187.3

4.44

972

3412

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24971

168819

1.49

91.79

5.9

5.2

2.6

2.8

mmol/l

125.05

23135

156122

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1385

5463

1.85

91.00

1.6

221.7

300.4

titre

0.52

279

(3028308) Erythrocytes [#/volume] in Pleural fluid

465

1160

2.89

89.07

1.5

66988.1

56428.5

e6/l

0.25

269

706

(40768806) Pleura Pathology biopsy report

429

1022

3.03

88.98

1.5

—

(40768441) Liver Pathology biopsy report

326

656

3.58

87.94

1.6

1.4

—

(3036489) Thrombin time

1306

5140

1.85

86.33

2.1

2.0

22.3

21.5

2.16

1177

4433

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

102

12.39

85.07

1.1

—

(40768443) Skin Pathology biopsy report

1527

6345

1.76

84.44

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

498

1339

2.69

83.15

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1428

5857

1.78

82.49

2.1

1.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1427

5885

1.77

80.89

1.1

3.2

8.7

u/ml

0.52

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23638

158918

1.38

80.57

4.7

4.1

1.4

1.3

mmol/l

20.13

21564

145818

(3000492) Spirometry study

3012

14947

1.49

80.43

1.6

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

686

2188

2.27

79.90

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

401

981

2.95

79.51

1.3

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

578

1718

2.43

78.81

3.1

2.7

1178.4

6768.2

u/ml

0.44

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1796

7952

1.65

78.66

3.1

2.5

0.3

e6/l

0.20

1750

7715

(3012441) Differential panel - Pleural fluid

427

1096

2.81

77.76

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1318

5376

1.79

77.47

1.9

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

801

2765

2.10

76.83

1.7

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2153

10035

1.58

76.43

2.4

2.2

11.9

14.4

nmol/l

29.42

1847

8969

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

830

2914

2.07

76.15

1.6

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

451

1206

2.70

76.11

1.8

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

425

1104

2.78

75.73

1.8

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

359

850

3.04

75.28

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

893

3240

2.00

74.93

3.5

3.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

440

1172

2.71

74.81

3.4

2.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

386

959

2.90

74.53

1.4

1.3

541.5

429.1

u/l

0.27

362

894

(1761868) Lipid panel - Serum or Plasma

6796

59166

0.76

74.31

3.3

3.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

576

1757

2.37

74.24

7.3

6.1

12.2

11.7

mg/l

1.82

517

1612

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

815

2873

2.06

73.97

1.7

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

714

2396

2.16

73.57

1.7

1.6

0.7

0.8

g/l

2.33

556

1798

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

988

3753

1.91

72.64

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24430

165694

1.39

72.53

5.2

4.6

4.5

4.7

mmol/l

121.02

22733

153921

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24268

164424

1.38

72.38

5.2

4.6

1.4

1.5

mmol/l

34.32

22361

151955

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3929

20898

1.40

71.72

5.0

4.7

32.6

32.3

0.95

2794

14210

(4281824)

349

839

3.00

71.35

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

7287

42568

1.30

71.22

5.3

4.0

0.0

estimate

0.07

1907

13456

(40760892) CBC W Ordered Manual Differential panel - Blood

5846

33135

1.33

71.03

5.3

4.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

849

3108

1.98

69.46

3.5

3.1

0.8

nmol/l

1.64

661

2422

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

14528

92477

1.25

68.95

2.7

2.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

281

607

3.33

68.31

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

384

999

2.77

68.27

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

294

655

3.23

68.12

1.7

1.5

3.7

mg/l

0.07

280

624

(3004809) Band form neutrophils/100 leukocytes in Blood

561

1770

2.29

67.02

3.3

2.9

1.7

1.2

2.14

455

1326

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

919

3510

1.90

66.43

3.5

2.8

1.8

1.6

mg/l

7.29

854

3136

(21494755) Public health laboratory ask at order entry panel

1190

13985

0.59

65.80

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

440

1256

2.53

65.33

2.1

2.2

—

0.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

380

1009

2.71

65.05

1.4

1.3

6.8

6.5

mmol/l

1.01

346

924

(21494434) Karyotype in Bone marrow

376

993

2.73

65.02

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

470

1395

2.43

64.32

3.8

3.7

—

(3017181) Myelocytes/100 leukocytes in Blood

2460

12229

1.48

64.30

4.3

3.9

1.0

0.7

4.26

787

2523

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

310

741

3.01

64.04

1.3

12.0

13.5

u/l

0.46

289

670

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

602

2023

2.15

61.83

1.8

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1115

4638

1.75

61.12

1.6

17.0

2.0

iu/ml

0.63

268

1002

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

254

555

3.29

60.72

4.5

1.2

60.7

263.0

u/ml

3.64

121

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

249

538

3.33

60.57

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

249

538

3.33

60.57

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1004

4066

1.79

60.27

1.8

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

426

1246

2.46

60.17

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

1010

4119

1.78

59.22

5.1

3.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

666

2370

2.03

58.92

1.6

1.4

—

(3044927) Protein electrophoresis panel - Urine

499

1585

2.27

58.73

1.2

—

(3003338) MCHC [Mass/volume]

20568

137238

1.26

58.56

30.2

15.7

330.8

332.6

g/l

132.46

20426

136155

(3017732) Neutrophils [#/volume] in Blood

2144

10575

1.48

58.01

2.9

2.8

4.2

4.0

e9/l

1.44

1537

7980

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

364

1007

2.60

57.61

1.7

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

364

1007

2.60

57.61

1.7

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

364

1007

2.60

57.61

1.7

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

222

460

3.47

57.54

2.9

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

422

1258

2.42

57.26

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1847

8856

1.52

57.20

3.0

4.3

4.5

pmol/l

3.99

1609

7781

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

575

1958

2.12

57.13

1.1

1.6

1.5

g/l

2.72

517

1761

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

969

3947

1.78

57.04

1.1

5.8

8.4

u/ml

0.61

443

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

316

818

2.78

56.77

1.5

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

309

792

2.81

56.53

1.4

1.5

13.4

13.2

u/l

0.15

302

761

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5051

28831

1.31

56.46

1.3

30.0

40.5

iu/ml

4.33

1550

9297

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

657

2366

2.01

56.26

1.6

1.4

28.4

18.4

u/ml

1.13

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

311

805

2.78

55.89

1.5

1.3

—

(3039000) Anion gap in Blood

824

3217

1.85

55.65

6.8

6.6

11.2

11.3

mmol/l

0.85

754

2926

(3018572) Chloride [Moles/volume] in Blood

824

3218

1.85

55.60

6.8

6.6

105.2

104.9

mmol/l

1.07

754

2927

(44806118)

426

1308

2.35

54.20

1.7

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

851

3385

1.82

54.16

4.5

3.0

7.7

mmol/l

0.06

835

3320

(44790048)

426

1309

2.34

54.11

1.7

1.5

—

(44790047)

426

1309

2.34

54.11

1.7

1.5

—

(44790049)

426

1309

2.34

54.11

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

285

720

2.85

53.55

4.2

3.8

—

(3008037) Lactate [Moles/volume] in Venous blood

883

3569

1.79

53.32

4.4

2.9

1.6

mmol/l

0.71

868

3496

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2867

15144

1.39

53.29

3.9

3.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

459

1467

2.26

53.28

1.2

56.8

58.0

u/l

0.13

305

958

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

633

2303

1.99

52.70

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1080

4643

1.69

52.51

6.3

5.7

1.2

1.3

mmol/l

1.96

958

4133

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1096

4733

1.68

52.41

1.6

1.2

g/l

0.10

1046

4487

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1440

6672

1.57

51.87

1.9

2.0

39.2

39.1

u/l

0.10

1245

5861

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

628

2292

1.98

51.83

1.2

—

(3003181) Sodium [Moles/volume] in Urine

702

2669

1.90

51.43

1.4

59.9

63.5

mmol/l

1.52

555

2121

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

602

2173

2.00

51.24

1.6

1.5

116.7

115.7

u/ml

0.07

130

491

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1071

4629

1.68

51.04

1.6

0.2

g/l

0.06

1019

4390

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4746

27201

1.30

50.77

1.3

12.7

13.3

u/ml

0.16

1606

10568

(3023487) Leukocytes [#/volume] in Peritoneal fluid

192

393

3.51

50.73

2.5

2.2

3657.5

2340.3

e6/l

0.17

143

274

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

248

598

2.98

50.59

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

248

598

2.98

50.59

1.5

1.3

—

(3000330) Specific gravity of Urine by Test strip

1701

8252

1.50

49.66

4.5

3.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

595

2168

1.98

49.34

1.3

306.2

280.9

u/ml

1.02

396

1429

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

399

1245

2.31

48.99

1.2

127.1

131.8

titre

—

(3051611) Lipemic interference index of Serum or Plasma

458

1518

2.17

48.75

4.0

3.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

399

1249

2.30

48.64

1.2

212.8

181.0

titre

0.27

221

(3047189) Immunofixation for 24 hour Urine

209

466

3.22

48.51

1.5

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

2287

11806

1.42

48.30

4.4

3.9

0.1

2.92

707

2360

(3011412) CD3 cells [#/volume] in Blood

309

861

2.58

48.30

2.2

1.1

e9/l

0.23

165

471

(3033799) Differential panel - Peritoneal fluid

167

322

3.72

48.07

2.0

2.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

218

503

3.11

47.90

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

850

3512

1.75

47.64

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

536

1934

2.00

45.71

3.1

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

789

3238

1.76

45.26

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

395

1272

2.24

45.11

3.9

3.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

288

802

2.58

45.10

1.2

31.5

21.4

u/l

1.56

241

679

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

294

832

2.54

44.58

1.2

100.3

87.1

u/l

1.06

251

719

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

250

652

2.75

44.42

2.3

2.2

487.4

507.5

e6/l

0.11

214

561

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

577

2161

1.93

44.24

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

285

799

2.56

44.05

1.8

1.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

370

1171

2.27

44.02

3.4

2.8

59.2

60.9

0.65

268

755

(3002179) Metamyelocytes/100 leukocytes in Blood

2169

11269

1.41

44.00

4.0

3.7

0.7

0.5

1.58

565

1874

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

242

624

2.79

43.91

2.3

2.2

0.2

e9/l

0.01

215

555

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

562

2098

1.93

43.51

1.4

1.2

2.1

2.0

nmol/l

0.04

534

2022

(3045414) Leukocytes [Presence] in Urine

1495

7278

1.49

42.78

2.0

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

317

950

2.40

42.65

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

315

944

2.40

42.38

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

654

2591

1.82

42.19

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

558

2108

1.91

41.72

1.4

1.2

0.2

nmol/l

0.53

153

(3025159) Blasts/100 leukocytes in Blood

2152

11284

1.39

41.27

4.4

4.0

0.1

0.2

0.80

613

2051

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

525

1956

1.93

40.90

2.6

1.9

24.2

26.2

mg/l

0.33

122

526

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

165

354

3.34

40.75

2.4

2.0

6179.0

14254.8

e6/l

0.62

102

183

(3038177) Helicobacter pylori Ab [Presence] in Serum

611

2399

1.84

40.58

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3247

18193

1.31

40.22

1.9

1.8

1.6

1.5

13.66

2737

15880

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

513

1908

1.94

40.18

1.4

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

40.09

1.0

0.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

204

504

2.90

40.01

2.6

2.7

38.5

42.9

1.57

169

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2083

10921

1.39

39.93

2.5

2.4

25.9

27.5

au/ml

0.16

556

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1917

9909

1.41

39.92

1.3

44.6

49.5

au/ml

0.38

438

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

531

2003

1.91

39.90

1.4

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

769

3248

1.71

39.89

1.2

166.7

125.7

titre

0.18

(4062490)

435

1532

2.04

39.69

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

119

206

4.14

39.58

2.8

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

494

1824

1.95

39.52

1.5

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

434

1533

2.04

39.29

1.4

0.4

g/l

0.07

322

1076

(3028192) IgG subclass 2 [Mass/volume] in Serum

434

1533

2.04

39.29

1.4

2.8

3.1

g/l

2.83

320

1071

(3027135) IgG subclass 1 [Mass/volume] in Serum

434

1534

2.04

39.22

1.4

6.7

6.8

g/l

0.23

320

1070

(3036603) Volume of Urine

297

907

2.35

38.39

1.7

1.4

1906.4

1984.4

0.29

203

(3035880) pH of Pleural fluid

225

601

2.69

38.30

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

253

723

2.51

37.70

2.3

614.6

915.7

e6/l

1.25

115

317

(3026250) Tacrolimus [Mass/volume] in Blood

221

601

2.64

36.37

36.7

35.3

7.1

7.4

ug/l

1.64

199

550

(1175426) CD3 cells/100 lymphocytes in Blood

228

630

2.60

36.37

1.9

2.0

70.7

72.8

1.12

215

601

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

224

616

2.61

36.08

1.9

15.2

15.4

0.05

114

282

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

6.19

35.88

1.2

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

123

239

3.69

35.16

1.5

1.4

20.0

26.6

1.54

100

191

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

484

1848

1.89

35.12

1.4

1.2

—

nmol/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

542

2147

1.82

35.04

1.1

—

(40765096) Chromosome analysis panel by Banding

108

191

4.05

35.01

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

142

306

3.33

34.91

1.5

1.3

3.6

3.4

mmol/l

0.24

132

276

(3010375) cycloSPORINE [Mass/volume] in Blood

217

598

2.60

34.83

31.7

27.7

113.6

118.6

ug/l

0.56

180

487

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

172

418

2.95

34.79

2.0

1.4

—

(3045424) Erythrocytes [Presence] in Urine

642

2681

1.73

34.72

1.5

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

141

305

3.31

34.47

1.7

1.5

13.1

12.3

g/l

0.44

112

215

(3015235) Bicarbonate [Moles/volume] in Capillary blood

865

3921

1.59

34.12

3.3

3.0

24.4

24.9

mmol/l

2.29

768

3448

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

172

423

2.92

34.09

3.4

3.1

—

(3017704) Immunofixation for Urine

254

764

2.39

34.01

1.4

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

1810

9556

1.38

33.09

1.3

206.3

234.7

u/ml

0.43

1660

8885

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

167

411

2.91

33.08

2.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

167

412

2.91

32.94

2.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

455

1743

1.88

32.71

1.4

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

339

1173

2.08

32.51

1.8

0.4

1.1

g/24h

1.99

(3042631) Mycobacterium sp identified in Specimen

469

1824

1.85

32.19

2.9

2.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

937

4389

1.54

32.07

1.7

1.6

16393.5

12838.5

e6/l

1.33

686

3211

(3023419) Bacteria identified in Sputum by Culture

489

1935

1.82

31.77

2.7

2.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

207

584

2.54

31.75

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1379

13605

0.71

31.73

1.9

1.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

154

371

2.98

31.67

1.5

1.4

62.0

62.5

0.06

125

292

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

586

2450

1.72

31.59

1.4

152.2

72.9

pmol/l

5.22

572

2392

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

269

858

2.25

31.59

1.6

1.5

4.7

6.3

u/l

0.95

137

379

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3821

22474

1.25

31.40

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

153

370

2.96

31.27

1.5

1.9

20350.8

37291.5

u/ml

0.25

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

436

1681

1.87

30.76

1.6

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

590

2509

1.69

29.93

1.3

1.2

36.3

23.3

u/l

1.86

514

2172

(3009214) Lutropin [Units/volume] in Serum or Plasma

656

2877

1.64

29.61

1.4

1.3

11.5

10.1

u/l

1.56

535

2310

(21494815) CD4 cells/100 lymphocytes in Specimen

246

777

2.27

29.59

1.9

2.2

39.5

44.8

0.87

122

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

312

1088

2.06

29.37

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

831

8863

0.66

29.15

1.5

—

(3044007) Cell count panel - Peritoneal fluid

137

326

3.01

28.82

2.4

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

137

327

3.00

28.67

1.7

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

264

871

2.18

28.64

2.4

2.0

17.1

16.8

umol/l

0.05

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

903

4312

1.51

28.30

2.5

2.3

123.3

109.4

ug/min

0.42

525

2543

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

316

1125

2.02

28.16

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

613

2683

1.65

27.91

1.5

1.4

—

(1616796) Gas panel - Central venous blood

720

3281

1.58

27.82

4.3

3.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

884

4230

1.51

27.44

2.1

12.5

10.8

mg/l

8.12

815

3921

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

232

739

2.25

27.41

1.9

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

991

4862

1.47

27.22

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

314

1137

1.98

26.72

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.59

26.62

1.3

1.1

1.7

2.7

ug/l

0.56

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

203

620

2.35

26.42

2.5

2.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

267

3.14

26.41

1.4

1.6

26.0

45.5

g/l

0.41

200

(3006245) CD3-CD19+ cells/100 cells in Blood

128

310

2.96

26.18

2.0

10.4

8.5

0.88

115

288

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

115

263

3.13

25.88

1.3

324.4

25.7

ug/l

0.86

125

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

232

759

2.19

25.75

1.2

—

(3005570) Glucose [Moles/volume] in Urine

403

1611

1.80

25.43

1.9

—

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

126

308

2.93

25.38

2.0

1.9

29.2

26.7

1.03

117

290

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1249

6491

1.39

25.04

1.2

1.3

0.3

0.7

u/ml

2.68

124

596

(3010503) CD19 cells [#/volume] in Blood

186

561

2.38

24.92

2.3

0.2

e9/l

0.41

180

541

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

190

580

2.35

24.79

1.9

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

189

578

2.34

24.56

1.9

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

189

578

2.34

24.56

1.9

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

189

578

2.34

24.56

1.9

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

728

3429

1.53

24.36

1.2

5.0

6.3

u/ml

0.16

272

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

222

737

2.16

23.82

2.6

2.0

91.7

97.6

1.38

211

689

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

494

2137

1.66

23.60

1.3

1.2

3.7

3.9

u/ml

0.16

229

957

(3006270) Folate [Moles/volume] in Blood

352

1386

1.82

23.38

1.3

1.2

318.7

363.7

nmol/l

3.69

279

1158

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.09

23.36

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

747

3572

1.51

23.31

2.5

2.2

125.4

131.8

g/l

8.23

504

2617

(3026389) Candida sp identified in Specimen by Organism specific culture

503

2194

1.65

23.29

1.5

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

906

4520

1.45

22.85

1.3

22.9

43.8

u/ml

2.13

280

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

221

749

2.12

22.54

2.2

2.5

1071.7

718.9

u/ml

1.66

214

741

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

318

1227

1.86

22.53

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

124

322

2.76

22.48

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

4.52

22.40

2.4

1.9

77.7

77.3

pmol/l

0.01

(3028626) Oxygen [Partial pressure] in Capillary blood

689

3268

1.52

22.35

3.2

2.9

7.9

8.0

kpa

1.03

646

3033

(3042733) HLA Ab [Presence] in Serum

173

532

2.33

22.26

5.6

5.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

150

433

2.48

22.13

1.9

1.6

2.0

umol/l

0.02

143

404

(3006922) Hepatitis E virus Ab [Presence] in Serum

268

983

1.96

22.10

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

42.88

22.09

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

437

1868

1.68

21.88

1.1

3.9

3.3

u/ml

0.21

138

865

(3021162) Amylase [Enzymatic activity/volume] in Specimen

102

4.28

21.37

2.6

3.0

805.4

4394.0

u/l

1.22

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

497

2216

1.61

21.13

1.3

1.2

3.1

4.0

u/ml

0.54

168

785

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

115

297

2.77

21.10

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

246

894

1.97

20.85

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

836

4189

1.44

20.63

1.3

8.8

7.0

u/ml

0.35

122

700

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

826

4130

1.44

20.62

1.3

5.4

6.8

u/ml

0.25

452

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

102

4.21

20.61

1.3

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

246

899

1.96

20.54

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

710

3453

1.48

20.45

1.2

11.9

16.8

u/ml

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

192

643

2.14

20.24

1.6

1.5

9.4

8.8

ug/l

0.14

180

565

(3011985) Renin [Units/volume] in Plasma

478

2135

1.61

20.20

1.3

1.4

75.0

59.6

mu/l

0.67

423

1900

(3024471) HLA-A [Type]

155

476

2.33

20.07

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

268

1018

1.89

19.99

1.4

13.5

13.1

umol/l

0.42

252

964

(3006462) Nitrate [Presence] in Urine

209

728

2.06

19.92

4.5

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

114

303

2.69

19.86

1.9

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

132

3.69

19.66

1.6

54.9

44.3

umol/l

1.29

132

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

106

4.05

19.66

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

142

424

2.40

19.57

1.2

1.1

—

(3024932) HLA-DR beta [Type]

152

470

2.32

19.40

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

969

5044

1.39

19.27

1.6

1.8

—

(3048879) Bone marrow aspiration report

118

326

2.59

19.10

1.7

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2098

12164

1.25

19.09

4.7

3.0

1.2

mmol/l

1.14

1893

10271

(4211845)

221

799

1.98

19.06

4.4

2.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

208

737

2.02

18.97

1.2

1.1

3.0

4.5

iu/ml

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

117

324

2.59

18.85

1.5

1.4

2.9

2.7

0.09

264

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

119

333

2.56

18.79

2.6

2.5

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

108

290

2.67

18.49

1.5

1.4

21.9

22.8

0.11

258

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

415

2.36

18.33

1.6

—

(3044941) Cell count panel - Synovial fluid

583

2788

1.50

18.28

1.5

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

206

2.99

18.08

11.1

10.4

4.8

5.5

mmol/l

1.35

206

(3041096) Erythrocytes [Presence] in Urine by Automated

6464

41555

1.14

18.04

4.2

3.2

—

(3021788) Differential panel - Synovial fluid

665

3275

1.46

18.03

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

439

1980

1.59

17.89

1.3

283.1

274.2

pmol/l

0.22

359

1496

(3003129) Base excess in Capillary blood by calculation

134

408

2.35

17.75

2.1

1.6

0.3

0.9

mmol/l

0.66

126

388

(3014271) Vancomycin [Susceptibility]

216

801

1.93

17.38

2.9

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

556

2665

1.50

17.27

1.4

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

272

1092

1.79

17.11

2.4

2.5

—

(40762365) Oxygen content in Arterial blood by calculation

202

2.94

17.01

4.2

2.5

14.4

15.4

ml/dl

1.67

186

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

285

1163

1.76

16.97

1.0

293.3

539.6

mg/l

0.48

247

1048

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7103

46103

1.13

16.93

1.7

1.4

mmol/l

3.82

6137

38289

(3000060) B lymphocytes [#/volume] in Blood

215

2.86

16.83

1.9

2.0

2160.7

135.8

e6/l

0.65

137

(3023420) DNA double strand Ab [Units/volume] in Serum

380

1681

1.62

16.79

1.5

20.1

29.3

iu/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

178

624

2.04

16.77

8.1

5.3

991.9

1702.9

mg/l

0.26

137

434

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

159

3.19

16.69

3.0

1.4

52.0

61.3

u/l

0.20

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

236

2.76

16.67

1.2

—

(3021901) Oxygen saturation in Capillary blood

583

2843

1.47

16.65

3.3

2.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

155

519

2.14

16.46

1.9

1.5

27.6

29.6

umol/l

1.38

149

498

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

212

798

1.90

16.36

2.2

105.6

139.6

ug/min

0.28

176

(4146454)

432

1984

1.56

16.34

2.9

2.7

—

(3008295) Osmolality of Serum or Plasma

327

1403

1.67

16.29

1.4

279.0

277.7

mosm/kgh2o

0.37

241

1069

(40768446) Kidney Pathology biopsy report

168

584

2.06

16.21

1.8

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

230

892

1.85

16.21

2.0

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

581

2848

1.47

16.18

3.6

3.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

382

1716

1.60

15.89

1.4

181468.6

117489.2

e6/l

0.83

270

1180

(3039162) Centromere protein B Ab [Units/volume] in Serum

439

2039

1.55

15.82

1.2

1.3

49.7

56.9

u/ml

0.22

142

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

167

585

2.05

15.80

2.8

2.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1161

1.72

15.57

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

205

2.83

15.54

1.7

1.5

103.4

124.2

ug/l

0.94

170

(40759836) Histone Ab [Presence] in Serum by Immunoblot

278

1159

1.72

15.42

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1170

1.72

15.40

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

278

1162

1.72

15.28

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1169

1.71

15.21

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1170

1.71

15.16

1.2

—

(3022621) pH of Urine by Test strip

1838

10772

1.23

15.11

3.6

2.9

—

(3004616) Nuclear Ab [Presence] in Serum

433

2034

1.53

14.86

1.3

—

(3010421) pH of Blood

751

3920

1.38

14.78

5.2

3.9

7.4

0.11

629

3278

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

647

3293

1.41

14.77

1.2

35.8

47.0

u/ml

0.98

347

(4268621)

326

1436

1.63

14.72

2.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

113

348

2.32

14.68

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

161

3.02

14.66

1.6

1.4

54.2

46.8

pmol/l

0.22

130

(3016038) Potassium [Moles/volume] in Urine

249

1024

1.74

14.52

1.2

1.1

32.8

33.7

mmol/l

0.24

212

851

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.69

14.30

2.4

2.7

54.4

59.6

0.33

(3027315) Oxygen [Partial pressure] in Blood

659

3388

1.40

14.21

5.4

3.9

8.4

8.5

kpa

1.01

640

3299

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

117

372

2.25

14.16

1.2

334.2

284.9

pmol/l

0.35

267

(3051593) INR in Capillary blood by Coagulation assay

202

788

1.84

14.05

8.7

10.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

260

2.50

13.91

2.0

1.4

48.7

31.6

u/l

0.34

228

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

189

726

1.87

13.81

1.1

27.2

21.2

u/l

0.83

158

527

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

28.57

13.76

1.3

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

188

723

1.86

13.69

1.1

92.3

82.3

u/l

0.86

159

553

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

5.36

13.57

5.7

2.6

0.3

0.5

umol/l

0.74

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

181

2.81

13.51

1.3

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

128

3.18

13.43

1.3

20.3

27.4

0.85

(3013290) Carbon dioxide [Partial pressure] in Blood

649

3365

1.39

13.34

5.4

3.9

5.0

kpa

0.16

630

3277

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2816

17380

1.17

13.27

1.6

—

(3012501) Base excess in Blood by calculation

648

3364

1.38

13.23

5.4

3.9

2.8

2.5

mmol/l

1.57

463

2293

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

344

1579

1.56

13.15

1.2

1.1

95.1

96.3

0.36

323

1477

(3017315) Amylase [Enzymatic activity/volume] in Urine

217

886

1.76

13.03

1.2

369.1

344.5

u/l

0.06

195

827

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

671

3513

1.37

13.01

1.8

1.7

0.9

0.8

nmol/l

1.28

557

2903

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

158

2.90

12.91

1.4

10.9

10.6

0.03

(3045683) HLA typing for celiac disease panel - Blood or Tissue

195

774

1.80

12.88

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

732

3893

1.35

12.86

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

450

2202

1.47

12.75

1.2

1.1

—

(3018133) Calcium [Moles/volume] in Urine

193

2.67

12.52

1.3

1.6

2.4

2.7

mmol/l

0.85

169

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

305

1379

1.59

12.47

1.7

1.6

—

(3004775) Volume in Urine collected for unspecified duration

311

1413

1.58

12.46

2.6

2.3

721.7

668.4

1.22

212

985

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

281

1248

1.61

12.37

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

135

3.02

12.35

1.5

1.2

610.6

307.4

u/l

0.20

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

510

2572

1.42

12.34

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

353

1657

1.53

12.25

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

245

1054

1.67

12.23

3.1

1.8

17.7

16.3

nmol/l

1.79

236

977

(21494814) CD8 cells/100 lymphocytes in Specimen

100

318

2.25

12.17

1.8

2.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

3.94

12.14

1.2

122.1

326.7

u/l

0.48

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

3.71

12.11

2.3

2.7

19.4

11.4

0.62

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

4.17

12.02

1.4

1.2

14.6

16.4

pmol/l

0.47

(3008536) Aspergillus sp Ab [Presence] in Serum

223

2.50

11.97

1.8

1.7

—

(4306422)

443

2191

1.45

11.92

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

317

2.23

11.87

1.2

1.3

90.3

62.9

mu/l

0.54

224

(3020491) Glucose [Moles/volume] in Blood

259

1140

1.63

11.85

1.8

1.9

7.4

7.0

mmol/l

1.21

169

785

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

343

1614

1.52

11.79

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

244

1062

1.65

11.67

1.3

48.1

75.3

titre

0.65

(4015189)

127

452

2.01

11.66

2.2

2.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

674

3597

1.35

11.62

1.7

1.8

4.9

17.1

iu/l

1.08

186

1341

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

428

2114

1.45

11.61

1.2

1.1

121.2

117.7

1.31

396

1901

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

765

4162

1.32

11.57

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

611

3217

1.36

11.50

2.0

1.9

186.6

199.4

pmol/l

2.53

560

3054

(3020717) Zinc [Moles/volume] in Serum or Plasma

167

658

1.82

11.36

1.6

1.4

22.2

23.3

umol/l

0.19

162

617

(4212803)

109

3.15

11.17

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

102

340

2.15

11.13

1.2

1.3

17.0

16.6

umol/l

0.41

308

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

122

437

2.00

11.03

4.7

1.8

1.3

1.0

ug/l

0.34

117

407

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

7.57

10.98

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

317

1491

1.52

10.96

1.5

1.3

32.7

32.9

u/l

0.04

255

1127

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

124

448

1.98

10.96

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

200

842

1.70

10.88

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

100

3.22

10.85

1.2

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

283

1302

1.56

10.81

1.6

21.6

25.5

u/ml

0.93

284

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

247

1101

1.61

10.79

1.3

179.5

466.2

titre

1.34

(3001964) Herpes simplex virus Ag [Presence] in Specimen

104

354

2.10

10.78

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

326

1549

1.51

10.76

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.27

10.64

2.4

2.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

126

463

1.95

10.63

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

601

3202

1.35

10.52

3.1

2.5

15.6

16.7

8.56

349

1663

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

321

1528

1.51

10.52

1.4

1.3

1.5

1.4

nmol/l

0.84

293

1377

(3006653) Thiamine [Moles/volume] in Blood

189

793

1.71

10.43

1.2

1.3

142.1

137.9

nmol/l

0.50

189

793

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

166

2.63

10.38

2.4

2.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

166

2.63

10.38

1.5

1.2

0.3

1.6

mmol/l

1.48

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

270

2.23

10.05

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

247

1121

1.58

10.05

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

143

562

1.82

9.88

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

175

2.53

9.85

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

328

1591

1.48

9.84

3.5

2.9

67.0

46.3

mg/l

0.52

233

1130

(4094501)

897

5095

1.27

9.82

1.1

—

(3023410) Appearance of Cerebral spinal fluid

302

1442

1.50

9.79

1.6

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

167

690

1.73

9.77

2.6

3.4

27.2

27.7

mu/l

0.05

159

643

(4024509)

324

1573

1.48

9.69

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

697

3842

1.30

9.67

1.3

565.5

560.4

mg/l

0.04

655

3653

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

625

3396

1.32

9.62

1.3

1.2

3.8

mmol/l

0.36

578

3200

(3004451) EKG impression Narrative

178

756

1.69

9.45

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

125

2.80

9.44

1.1

16.1

18.8

u/l

0.56

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

122

463

1.89

9.42

1.2

109.9

113.2

0.54

104

412

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

223

2.31

9.41

4.8

4.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

146

587

1.78

9.39

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

434

1.91

9.35

1.3

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

793

4468

1.28

9.30

1.9

1.7

42.3

42.4

nmol/l

0.02

764

4338

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

195

853

1.64

9.26

1.9

2.8

2.6

u/field

0.13

133

589

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

396

2015

1.41

9.25

2.1

1.8

1198.1

3613.7

u/l

2.93

112

741

(3016750) Collection duration of Urine

223

1009

1.58

9.24

2.5

2.1

491.7

501.8

min

0.91

174

768

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

129

503

1.84

9.18

1.2

0.3

g/l

0.25

102

413

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

253

1182

1.53

9.12

1.5

1.3

0.3

nmol/l

0.09

186

914

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

144

2.63

9.10

2.2

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

144

2.63

9.10

2.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

128

2.74

9.06

1.3

1.2

74.8

119.6

ug/l

1.53

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

124

2.77

9.05

1.2

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

264

1249

1.51

8.99

1.3

1.2

2.3

9.3

u/ml

1.84

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

213

960

1.59

8.98

1.6

1.4

6.2

5.6

u/l

0.38

174

822

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

148

610

1.74

8.79

1.5

1.7

3.3

7.9

nmol/l

0.61

123

506

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

159

672

1.69

8.64

1.9

2.0

198.7

205.0

u/l

0.31

159

664

(3024316) Viscosity of Plasma

4.44

8.58

2.6

1.2

1.6

1.3

mpas

2.26

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1576

9612

1.18

8.57

1.2

114.9

141.5

iu/ml

2.14

554

3772

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

128

2.68

8.56

1.7

1.3

69.8

66.8

0.23

101

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

224

2.23

8.54

1.3

1.2

1207.1

114.9

ng/l

0.47

155

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

273

1316

1.49

8.52

1.2

70.5

83.8

u/ml

0.29

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

273

1320

1.48

8.40

1.3

1.2

40.9

50.8

u/ml

0.28

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

254

2.14

8.36

1.7

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

278

1351

1.47

8.35

1.2

64.8

55.0

u/ml

0.15

(3018834) Bilirubin.total [Presence] in Urine by Test strip

5.78

8.31

2.1

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

219

1014

1.55

8.27

1.5

—

(3017569) Oxygen content in Arterial blood

169

736

1.64

8.23

2.4

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

196

2.30

8.21

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

215

2.23

8.14

1.2

1.4

112250.8

279577.7

nmol/l

0.48

186

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.36

8.05

1.1

1.0

26.4

24.1

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.36

8.05

1.1

1.0

35.8

36.5

u/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

562

3091

1.30

8.01

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

196

892

1.57

7.99

1.5

1.6

7.8

9.1

umol/l

0.47

143

638

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

155

2.44

7.91

2.0

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

825

7230

0.81

7.82

1.6

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

257

2.09

7.78

1.5

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

783

1.60

7.69

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

100

382

1.87

7.67

6.2

5.8

65.8

71.6

1.24

319

(3041918) Cholesterol [Moles/volume] in Pleural fluid

235

2.13

7.65

1.5

1.1

1.5

mmol/l

0.13

113

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

274

2.04

7.59

2.4

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

151

2.41

7.44

2.5

1.2

39.1

83.1

ng/l

3.04

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

141

603

1.67

7.41

1.5

1.8

158.5

151.2

0.46

129

565

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

268

1326

1.45

7.40

1.9

2.1

2.8

2.2

u/field

0.60

118

510

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

130

544

1.71

7.40

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

130

546

1.70

7.31

1.2

1.3

39.3

40.0

g/l

0.24

292

(44806420)

120

493

1.74

7.29

2.5

2.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

595

3342

1.28

7.26

1.9

1.8

279.4

299.5

mu/l

0.91

551

3042

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

115

2.61

7.19

1.2

1.3

1.2

1.1

ml/s/173m2

0.20

(3014051) Protein [Presence] in Urine by Test strip

650

3701

1.26

7.10

2.5

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

309

1584

1.40

7.04

1.4

—

(44813793)

230

1119

1.47

6.96

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.33

6.96

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

764

1.57

6.94

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

439

2386

1.32

6.89

2.1

1.9

1.7

mmol/l

0.19

429

2332

(3028717) Thiamine [Mass/volume] in Blood

144

2.38

6.84

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

197

935

1.51

6.74

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

731

1.58

6.72

2.4

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.32

6.68

1.1

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

354

1879

1.35

6.55

2.3

2.1

3.2

7.4

titre

0.72

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

104

2.61

6.54

1.6

1.1

52.3

43.3

mg/l

1.11

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

177

830

1.53

6.43

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

190

2.14

6.41

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

110

459

1.71

6.39

3.0

6.6

7.6

mg/l

1.01

366

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

329

1734

1.36

6.38

1.2

1.1

2.1

1.4

iu/ml

0.56

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.42

6.20

1.0

1.2

166.7

163.5

ug/g

0.02

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

454

2520

1.29

6.16

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

203

2.08

6.15

2.7

2.6

0.5

0.6

u/field

0.21

203

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

143

646

1.58

6.14

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

257

1.95

6.12

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.92

6.11

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.86

6.10

5.3

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.02

6.01

1.3

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

590

3392

1.25

6.00

1.4

26.7

29.5

e6/l

0.11

451

2658

(3019977) pH of Arterial blood

186

896

1.49

5.98

3.0

2.4

7.4

0.03

304

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

590

3395

1.25

5.96

1.5

1.4

4940.4

2146.1

e6/l

0.34

471

2814

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

195

950

1.47

5.94

1.1

1.5

5.8

nmol/l

3.25

180

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

11.23

5.88

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.77

5.86

1.3

2.0

154.1

124.7

ug/l

0.19

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.80

5.71

2.9

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

125

2.34

5.71

1.2

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

415

2304

1.29

5.66

1.6

1.5

59.2

57.6

0.35

280

1462

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

343

1.77

5.60

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

9.83

5.55

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

120

535

1.60

5.49

1.5

1.4

16.0

15.5

pmol/l

0.20

108

444

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

211

1062

1.42

5.45

1.2

1.1

51.1

40.8

mg/l

1.40

189

879

(3014891) Appearance of Pleural fluid

170

2.10

5.42

1.9

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

164

788

1.49

5.39

1.6

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

385

1.71

5.37

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.80

5.32

5.7

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

221

1128

1.40

5.29

1.2

1.3

2.1

mmol/l

0.48

204

1052

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

236

1.91

5.26

3.0

2.5

114.3

58.1

mg/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.96

5.21

1.2

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

186

925

1.44

5.16

1.4

1.2

1.3

nmol/l

0.55

141

716

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

233

1.90

5.14

1.0

1.1

3.2

pmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

195

979

1.43

5.14

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

201

1015

1.42

5.13

1.1

336.1

276.9

mg/l

1.47

184

889

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

294

1580

1.33

5.12

1.8

1341.5

3396.7

titre

0.94

(3029075) Extractable nuclear Ab panel - Serum

101

440

1.64

5.10

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

252

1324

1.36

5.09

1.4

promille

0.20

195

999

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

105

2.38

5.08

1.2

1.1

12.2

12.5

iu/ml

0.02

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

203

1031

1.41

5.03

1.5

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

269

1433

1.34

4.98

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.97

4.95

12.9

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

364

2028

1.29

4.90

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

380

1.67

4.87

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.64

4.83

5.6

5.3

—

(3002619) Bacteria identified in Specimen by Culture

306

1.75

4.82

1.3

—

(3024263) Appearance of Synovial fluid

189

960

1.41

4.71

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.65

4.70

4.3

3.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

424

2422

1.25

4.67

4.8

5.0

354.1

368.6

umol/l

1.26

361

2082

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

390

2207

1.27

4.65

1.1

6.7

14.0

au/ml

—

109

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

151

738

1.46

4.63

1.2

1.1

1.2

1.1

u/l

0.37

340

(3040151) Glucose [Moles/volume] in Capillary blood

329

1825

1.29

4.61

6.0

11.8

7.4

7.6

mmol/l

0.45

254

1505

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

381

1.65

4.59

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

447

2575

1.24

4.58

1.1

80.2

4960.0

iu/ml

0.58

508

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

290

1.75

4.57

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

342

1909

1.28

4.57

2.0

1.8

89.1

89.7

0.86

337

1883

(3049242) von Willebrand panel - Platelet poor plasma

3.37

4.54

1.7

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

218

1.87

4.53

6.4

5.0

56.4

42.6

ug/min

1.01

164

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

383

1.64

4.51

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

380

2156

1.26

4.46

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

435

1.59

4.42

2.6

2.5

164.3

164.4

au/ml

0.00

(40757373) Influenza virus identified in Isolate

289

1.73

4.36

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

104

477

1.56

4.32

1.2

1.4

3.2

3.6

umol/l

0.68

437

(3006576) Bicarbonate [Moles/volume] in Blood

132

638

1.48

4.31

6.4

6.3

24.9

25.3

mmol/l

0.46

121

582

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

225

1198

1.34

4.25

1.4

1.3

1.1

1.3

u/ml

0.19

134

573

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

176

901

1.40

4.24

1.1

9.8

9.1

iu/ml

0.13

198

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3218

21389

1.08

4.22

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

129

2.11

4.21

1.1

1.2

31.3

17.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

173

1.94

4.20

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1058

0.65

4.17

1.4

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

354

1.64

4.12

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.38

4.12

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

112

2.17

4.07

1.4

1.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.73

4.02

1.1

5879.2

1528.6

ng/l

0.38

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

122

2.11

4.02

1.1

0.3

nmol/l

0.03

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.89

4.01

1.2

1.0

191.4

307.5

nmol/l

1.99

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

353

1.62

3.94

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.33

3.93

1.0

1.1

—

(1002224) Polysomnography panel

1035

6510

1.14

3.92

1.1

—

(3025315) Body weight

133

2.04

3.92

5.4

4.4

—

(3022689) Creatine [Moles/volume] in Urine

109

518

1.50

3.90

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

332

1.64

3.90

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

157

802

1.40

3.87

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

344

1.62

3.86

1.1

0.8

0.7

umol/24h

0.90

167

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

545

3267

1.20

3.84

1.3

221.7

214.1

miu/ml

0.16

207

1444

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

977

0.66

3.82

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

976

0.66

3.81

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

441

1.54

3.80

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.47

3.78

1.4

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.47

3.78

1.2

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.09

3.77

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

275

1.69

3.77

1.1

1.2

79.8

88.0

0.70

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

973

0.66

3.76

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

973

0.66

3.76

1.4

—

(3000012) Reticulocyte production index

157

807

1.39

3.75

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

148

758

1.40

3.62

3.9

—

(3008898) HLA-B27 [Presence]

767

4754

1.16

3.62

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

246

1363

1.29

3.58

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.22

3.58

2.3

4.2

1.2

1.6

mg/l

1.13

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

500

1.49

3.56

2.9

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

500

1.49

3.56

2.9

2.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.54

3.56

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

335

1.60

3.56

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

2.14

3.53

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

1.89

3.52

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

206

1.77

3.50

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.46

3.49

1.8

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

115

2.05

3.48

1.3

1.2

—

(4027681)

151

784

1.38

3.43

1.2

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.38

3.43

2.7

1.1

9.1

1.3

pmol/l

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.55

3.42

1.1

1.5

0.9

1.1

u/field

0.40

(3002621) Streptococcal DNAse B [Units/volume] in Serum

121

2.01

3.40

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

368

1.55

3.38

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.98

3.36

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

157

824

1.36

3.35

1.7

1.6

8.2

5.5

mmol/24h

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

844

0.66

3.32

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

282

1610

1.25

3.26

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

400

1.52

3.26

1.1

82.7

89.5

0.81

197

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.31

3.24

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

228

1271

1.28

3.21

1.8

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

138

715

1.38

3.21

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

810

0.66

3.18

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.71

3.14

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

279

1.61

3.14

1.5

1.3

219.9

201.6

titre

0.03

(3047352) Trisomy 18 risk [Likelihood] in Fetus

815

0.67

3.12

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

204

1868

0.78

3.11

1.6

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

275

1.61

3.08

1.2

72.6

76.1

0.24

(3034426) Prothrombin time (PT)

100

494

1.45

3.05

1.3

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

173

1.78

3.03

1.1

0.6

u/ml

0.04

111

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

414

1.49

2.99

1.1

82.0

88.7

1.16

201

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

514

1.43

2.99

1.4

1522160.0

2456540.8

iu/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

432

1.47

2.98

1.4

1.6

0.4

ug/l

0.21

277

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.17

2.95

1.0

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.86

2.95

3.1

3.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

202

1.70

2.92

1.9

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

357

2118

1.21

2.91

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.09

2.91

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

153

820

1.33

2.91

1.3

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.53

2.89

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.02

2.89

1.3

1.1

13.6

14.2

nmol/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

137

723

1.36

2.88

1.5

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

198

1.70

2.86

1.3

6.3

6.5

mmol/l

0.05

102

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

618

0.63

2.85

1.3

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

253

1.61

2.85

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.30

2.82

1.9

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.78

2.82

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

771

0.68

2.81

1.3

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

1.75

2.80

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

126

660

1.37

2.79

1.7

1.8

93.8

120.6

umol/l

0.79

327

(3051387) C reactive protein [Mass/volume] in Capillary blood

447

3728

0.85

2.72

4.3

3.4

26.8

25.3

mg/l

0.37

273

2431

(3019832) Treponema pallidum Ab [Presence] in Serum

1103

7135

1.11

2.72

1.6

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

119

621

1.37

2.71

2.4

2.3

61.0

54.7

umol/l

1.16

503

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1428

11104

0.91

2.71

1.3

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.02

2.70

1.1

38.5

60.3

u/l

1.46

(40762887) Creatinine [Moles/volume] in Blood

2.70

2.69

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

158

863

1.31

2.67

1.2

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

438

1.44

2.63

1.3

109.2

140.2

nmol/l

1.43

308

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

119

626

1.36

2.60

1.1

527.7

663.9

ng/l

0.15

144

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.38

2.58

1.2

1.4

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

3.02

2.54

2.2

1.5

0.6

0.2

1.07

(3025577) Chromium [Mass/volume] in Blood

203

1154

1.26

2.53

2.1

2.3

2.4

ug/l

0.14

163

972

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

159

878

1.30

2.50

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

383

0.58

2.43

1.1

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.91

2.40

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

243

1.56

2.37

1.3

59.2

49.0

0.70

114

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

215

1.60

2.37

1.1

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.92

2.37

1.2

1.6

0.7

umol/l

0.01

(3022475) Manganese [Moles/volume] in Blood

2.15

2.34

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

166

1.68

2.34

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

216

1.59

2.33

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

100

522

1.37

2.33

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

390

1.43

2.32

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

415

1.41

2.29

1.1

109.6

108.2

0.10

378

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

695

4439

1.12

2.22

1.5

—

(3027874) Urate [Moles/volume] in Urine

2.21

2.22

1.1

1.0

1.6

1.8

mmol/l

0.26

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

690

5495

0.89

2.18

1.7

4.2

3.5

mg/l

0.59

536

3888

(3026470) Cobalt [Mass/volume] in Blood

205

1190

1.23

2.18

2.0

4.2

3.8

ug/l

0.31

182

1056

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

5.95

2.17

1.2

1.0

21.4

22.3

umol/l

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

5.95

2.17

1.8

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

155

1394

0.79

2.16

1.0

0.2

0.5

u/ml

1.11

297

(3013166) Neutrophils/100 leukocytes in Synovial fluid

107

573

1.33

2.15

1.3

1.4

59.2

56.0

0.37

495

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.44

2.11

1.5

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

882

0.74

2.10

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

130

1188

0.78

2.08

1.5

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

119

1.74

2.01

1.1

9.6

10.2

u/l

0.06

119

(40763590) HLA-DQ beta [Type]

2.75

2.00

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

1.62

2.00

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.04

1.98

1.1

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

115

631

1.30

1.98

2.8

3.0

29.7

28.6

umol/l

0.50

486

(3012565) Volume of 24 hour Urine

132

738

1.28

1.97

2.3

1.9

1917.5

2003.7

0.35

124

649

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

766

0.74

1.97

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

344

1.41

1.95

1.1

1.0

0.7

0.8

u/ml

0.18

167

(40765089) Chromosome analysis panel - Blood by G-banded

154

1.62

1.91

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

419

3406

0.88

1.90

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

480

1.34

1.89

1.7

1.9

9.7

9.1

mg/l

0.49

396

(40760409) HLA-A [Type] by High resolution

2.65

1.88

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.65

1.88

1.0

—

(40760410) HLA-B [Type] by High resolution

2.65

1.88

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

238

0.54

1.86

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

594

4721

0.90

1.86

1.4

1.3

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.14

1.86

5.4

0.8

1.2

mg/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

172

1.58

1.86

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

562

3590

1.12

1.86

1.9

1.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.68

1.81

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.68

1.81

2.3

6.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

159

0.45

1.79

1.4

1.2

—

(3027008) Opiates [Presence] in Urine

425

3435

0.88

1.79

1.7

1.9

—

(3027944) Amphetamines [Presence] in Urine

416

3366

0.88

1.78

1.7

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.86

1.78

1.1

—

(3028300) Cannabinoids [Presence] in Urine

426

3441

0.88

1.78

1.7

2.0

—

(3013862) HLA-DP [Type]

2.55

1.77

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

321

1.40

1.77

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

115

643

1.28

1.75

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1430

9561

1.07

1.75

1.9

1.7

—

(3045716) Anion gap in Serum or Plasma

138

790

1.25

1.74

2.8

2.4

8.3

9.2

mmol/l

1.56

576

(3000764) Benzodiazepines [Presence] in Urine

424

3417

0.88

1.72

1.7

2.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.38

1.72

6.6

9.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

287

1764

1.16

1.71

1.6

1.5

24.5

29.5

1.79

184

1098

(3023511) Choriogonadotropin [Units/volume] in Urine

176

1036

1.21

1.71

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.06

1.71

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

201

1708

0.84

1.68

1.1

2.6

3.1

u/ml

0.20

633

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

3.97

1.67

3.8

6.1

1.4

10.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.86

1.65

1.3

1.6

0.4

0.1

u/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

153

0.47

1.64

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

682

1.26

1.63

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

150

1.57

1.62

1.6

1.3

901.7

297.2

mg/24h

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

202

1.49

1.61

1.4

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1283

8576

1.07

1.61

1.8

1.7

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.83

1.60

1.8

1.4

0.7

2.2

mg/l

1.67

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.83

1.60

1.8

1.4

5.5

3.7

mg/l

0.44

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

536

1.28

1.52

1.6

1.2

9.1

2.7

ug/l

0.54

421

(3037556) Urate [Mass/volume] in Serum or Plasma

543

1.28

1.51

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

613

1.26

1.50

1.0

1.1

1570.8

1587.2

miu/ml

0.05

108

613

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

519

0.73

1.49

2.0

1.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

139

813

1.22

1.48

12.6

12.3

0.6

mmol/l

0.10

127

738

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.47

1.48

1.1

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

148

1.54

1.48

1.1

—

(3000285) Sodium [Moles/volume] in Blood

230

1.43

1.48

1.1

1.2

—

(4034850)

781

6045

0.92

1.48

13.4

9.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

160

1.52

1.47

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

470

1.29

1.46

11.2

8.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

138

1.55

1.43

2.1

2.4

0.5

0.9

mmol/l

0.97

(46235168) Fasting glucose [Moles/volume] in Blood

191

0.56

1.43

1.3

1.5

6.8

7.4

mmol/l

—

(3017509) Phencyclidine [Presence] in Urine

110

1.62

1.42

1.6

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

227

1.42

1.39

1.7

1.5

—

(3018291) Platelet Ab [Presence] in Serum

2.50

1.39

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.70

1.35

2.0

2.2

1.7

2.1

mg/l

0.85

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.48

1.32

1.4

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

107

1.60

1.31

1.3

1.6

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.98

1.31

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

491

1.27

1.31

1.9

1.6

8.9

ug/l

0.05

491

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

353

1.32

1.30

1.2

1.3

70.4

32.2

mg/l

0.22

261

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.16

1.30

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

416

1.29

11.7

8.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

360

1.31

1.29

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.65

1.28

1.5

1.2

—

(3016879) Cocaine [Presence] in Urine

403

3190

0.90

1.28

1.7

2.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

166

1.46

1.27

1.1

2.1

1.7

umol/24h

1.69

166

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.29

1.25

1.1

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.95

1.22

1.3

229.9

547.8

nmol/l

3.04

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.75

1.22

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

156

1.47

1.21

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.20

1.21

2.8

2.6

1.4

1.7

mu/l

—

(3019174) dRVVT (LA screen)

123

1.51

1.14

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

676

4485

1.08

1.13

2.1

1.8

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

464

1.25

1.12

1.5

1.3

37.6

38.8

0.09

317

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.73

1.10

32.0

12.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

203

1267

1.15

1.10

1.2

12.0

mmol/l

0.02

111

364

(21494567) Legionella sp IgM Ab [Presence] in Serum

120

1.49

1.04

1.0

1.1

—

(4198724)

443

1.24

1.04

1.7

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

367

1.27

1.03

1.6

2.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.08

1.02

1.0

1.1

1714.3

2160.0

titre

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

989

1.16

1.01

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

122

1.46

0.98

1.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

128

1.45

0.98

1.1

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

129

787

1.17

0.97

1.1

2.5

6.6

u/ml

2.79

128

(3030313) Adrenal Ab [Titer] in Serum

1.54

0.97

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

196

1584

0.88

0.96

1.1

3.6

3.3

u/ml

0.08

598

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

177

1.37

0.95

1.4

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

117

1.47

0.95

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

359

1.25

0.95

2.4

2.3

2.9

3.6

ug/l

1.19

128

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

178

1.36

0.93

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

178

1.36

0.93

1.4

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

176

0.65

0.92

1.3

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

214

1361

1.12

0.91

1.0

293.5

328.9

ng/l

1.31

155

954

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.14

0.91

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.14

0.91

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.14

0.91

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.14

0.91

1.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.14

0.91

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.14

0.91

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.14

0.91

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

120

735

1.17

0.88

1.2

63.7

57.7

0.22

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.53

0.87

1.2

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.04

0.87

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

214

1367

1.12

0.86

1.0

751.9

730.8

ng/l

0.25

152

920

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

141

878

1.15

0.85

1.2

1.1

ratio

1.17

308

(40761536) Microorganisms panel - Urine sediment

1821

12547

1.04

0.85

5.2

3.9

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

391

1.22

0.84

1.5

1.7

81.9

92.1

au/ml

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

352

0.77

0.83

1.3

1.4

8.5

mmol/l

0.03

208

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

214

1371

1.12

0.83

1.0

41.5

44.3

ng/l

0.33

153

941

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

226

1.30

0.82

2.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

279

1.25

0.78

1.4

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.74

0.77

1.7

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

366

2423

1.08

0.74

1.1

1.0

1.2

u/ml

0.22

142

900

(3010726) Horse dander IgE Ab [Units/volume] in Serum

248

1939

0.91

0.73

1.1

1.4

u/ml

0.00

429

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.61

0.72

1.1

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

131

1.36

0.72

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.71

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

348

1.21

0.70

2.4

2.6

7.7

7.6

mmol/l

0.08

204

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.72

0.70

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

139

0.67

0.70

5.7

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

139

0.67

0.70

2.8

3.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

342

2631

0.93

0.69

1.7

2.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.88

0.68

1.4

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

502

1.17

0.66

1.1

—

(3035060) Mercury [Moles/volume] in Blood

1.79

0.65

1.2

2.1

7.0

14.8

nmol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

161

1276

0.90

0.64

1.4

1.3

72.0

100.5

pmol/l

0.55

392

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

210

1.26

0.63

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.70

0.62

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

295

1.21

0.62

1.2

1.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

104

1.37

0.62

1.1

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.61

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

131

1044

0.90

0.60

1.3

1.5

g/l

0.61

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.3

—

452.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.71

0.58

1.0

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.50

0.57

1.4

1.0

0.1

0.0

mg/l

0.74

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

112

1.34

0.57

5.0

7.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

299

1.19

0.55

1.9

2.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

638

0.87

0.55

1.0

0.4

1.3

u/ml

0.40

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.59

0.54

1.0

1.2

4.2

2.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

177

1.25

0.53

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

232

1539

1.08

0.51

2.0

2.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

250

1.20

0.50

2.0

15.2

17.8

umol/l

1.26

250

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.37

0.48

1.1

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

562

0.88

0.48

2.6

2.5

142.9

151.5

nmol/l

0.18

488

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.47

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.47

0.47

1.6

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

506

0.87

0.45

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

322

2176

1.06

0.43

1.1

3.0

3.5

u/ml

0.38

151

998

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.47

0.43

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

110

713

1.10

0.43

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

196

1.20

0.42

1.0

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.55

0.42

1.0

0.1

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

116

757

1.09

0.41

1.1

1.0

1.5

1.3

u/ml

0.07

201

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.40

0.0

2.6

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

308

2087

1.05

0.39

1.1

0.7

1.1

u/ml

0.86

119

776

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

152

1.22

0.39

1.2

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

172

1.20

0.38

1.2

1.1

0.6

3.3

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

498

0.89

0.38

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

127

1.24

0.37

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

167

1.20

0.36

2.2

1.7

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.28

0.36

1.0

0.1

0.6

u/ml

0.73

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

252

0.85

0.34

1.2

82.8

64.5

u/ml

0.59

244

(3042517) Benzodiazepines panel - Urine

109

1.25

0.34

1.3

2.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

195

1.17

0.33

2.0

2.3

36.6

41.1

umol/l

0.50

166

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

455

0.89

0.33

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

455

0.89

0.33

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

455

0.89

0.33

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

455

0.89

0.33

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

131

1.20

0.30

2.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.24

0.27

1.3

1.1

—

mmol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.23

0.27

1.1

1.0

8.6

8.5

mmol/l

0.15

(3051101) Glucose [Moles/volume] in Cord blood

373

0.90

0.26

4.4

5.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.69

0.26

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

274

0.89

0.25

1.5

1.6

—

(3011288) Drugs identified in Urine by Screen method

303

2244

0.96

0.24

2.3

3.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.71

0.24

1.2

1.0

0.2

0.5

u/ml

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.27

0.23

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.32

0.23

2.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.28

0.23

1.0

1.5

22.2

19.4

e6/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.28

0.23

1.2

1.3

—

(3016135) IgD [Mass/volume] in Serum

1.28

0.23

1.0

1.1

26.8

93.2

mg/l

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

677

4732

1.02

0.21

1.4

1.3

31.3

34.1

iu/l

1.31

574

4119

(3012989) Citrate [Moles/time] in 24 hour Urine

1.19

0.21

1.0

1.3

2.5

2.3

mmol/24h

—

(3046861) Legionella sp Ag [Presence] in Urine

1.22

0.21

1.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

12.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.20

0.21

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

264

1951

0.97

0.21

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

459

1.07

0.20

1.9

—

(4133840)

469

0.93

0.20

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

108

732

1.05

0.19

1.0

2.0

0.7

u/ml

0.49

153

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.23

0.19

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

133

0.86

0.18

1.2

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

148

0.87

0.18

1.7

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

213

1.11

0.18

1.1

1.0

103.0

82.2

ug/l

1.06

168

(3025549) Creatine [Moles/time] in 24 hour Urine

145

1.13

0.18

1.6

1.5

—

14.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

125

1.14

0.17

1.9

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.84

0.17

1.0

0.0

u/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

213

0.91

0.16

1.1

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.77

0.16

1.0

—

(3013762) Body weight Measured

1.17

0.15

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

340

1.07

0.15

6.7

7.4

—

(3020650) Glucose [Presence] in Urine

404

0.94

0.15

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

266

1950

0.97

0.15

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

124

851

1.04

0.15

4.9

5.4

72.3

4374.1

u/ml

0.58

164

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

127

1.12

0.14

1.6

1.4

22.7

48.0

1.97

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.86

0.12

1.4

320.2

322.0

umol/24h

0.01

(3035611) Eosinophils/100 leukocytes in Synovial fluid

122

1.11

0.12

1.4

1.6

0.4

0.7

0.65

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

227

1.07

0.11

1.0

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.12

0.10

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

651

1.03

0.08

1.1

100.2

98.5

0.20

515

(3009677) Dengue virus Ab [Presence] in Serum

1.09

0.08

1.0

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.84

0.07

1.0

1.3

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

140

1.07

0.06

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

131

917

1.02

0.06

1.5

5.3

4.2

0.38

195

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

363

0.96

0.06

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

331

1.04

0.05

1.3

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.08

0.05

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

679

4879

0.99

0.05

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.91

0.05

1.5

22.1

24.0

mmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

163

1.05

0.04

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

122

0.94

0.04

2.4

2.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

149

1.05

0.04

2.0

2.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

333

1.03

0.04

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

121

851

1.02

0.04

1.2

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.92

0.03

1.0

0.0

0.8

u/ml

—

(3001729) Color of Synovial fluid

150

1.05

0.03

1.4

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

106

0.94

0.02

1.1

1.0

0.0

0.1

u/ml

—

(44806071)

201

1.03

0.02

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

206

0.97

0.02

8.2

9.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

494

1.01

0.01

1.3

1.2

18.5

23.9

0.27

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.04

0.00

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

122

868

1.00

0.00

15.7

16.6

1260.2

3206.9

nmol/l

0.57

116

831

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

690

1.00

0.00

1.1

25.5

8.7

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

284

2032

1.00

0.00

1.2

7.4

7.5

mmol/l

0.24

212

1450

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

367

0.99

0.00

1.4

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

115

824

1.00

0.00

12.4

12.0

752.1

2042.1

nmol/l

0.54

109

788

(3006442) Creatine [Moles/volume] in Serum or Plasma

164

1168

1.00

0.00

1.8

1.6

77.2

70.0

umol/l

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

160

0.98

0.00

1.1

1.0

0.2

0.7

u/ml

0.37

114

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.87

0.00

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.87

0.00

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3023006) Beef IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.3

—

(3034614) HLA Ag [Interpretation]

0.94

0.00

1.4

1.1

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.87

0.00

1.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(4038314)

0.99

0.00

1.2

1.3

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.97

0.00

1.0

1.4

—

2203.6

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

3.4

—

3.2

—

(3010422) Chicken meat IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

0.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.97

0.00

1.0

—

12403.9

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_COLORECANI_EXALLC – Benign neoplasm of colon, rectum, anus and anal canal

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm of colon, rectum, anus and anal canal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints